-DOCSTART- NN -X-

A DT O
64 CD B-Age
year NN I-Age
old JJ I-Age
female NN O
known VBN O
for IN O
HHT NNP B-Disease_disorder
is VBZ O
referred VBN O
to TO O
our PRP$ O
clinic NN B-Nonbiological_location
for IN O
recurrent NN B-Detailed_description
epistaxis NN B-Sign_symptom
for IN O
nearly RB B-Duration
50 CD I-Duration
years NNS I-Duration
. . O

She PRP O
has VBZ O
had VBN O
recurrent NN O
symptoms NNS O
since IN O
the DT O
age NN O
of IN O
16 CD O
when WRB O
her PRP$ O
condition NN O
was VBD O
diagnosed VBN O
. . O

All DT O
three CD O
of IN O
her PRP$ O
siblings NNS O
also RB O
were VBD O
diagnosed VBN O
with IN O
HHT NNP O
and CC O
her PRP$ O
mother NN O
passed VBD O
away RB O
from IN O
an DT O
intracranial JJ O
hemorrhage NN O
. . O

Eight CD O
years NNS O
prior RB O
to TO O
presentation VB O
she PRP O
had VBD O
undergone NN O
a DT O
left JJ B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
septodermoplasty JJ B-Therapeutic_procedure
via IN O
a DT O
lateral JJ B-Detailed_description
rhinotomy NN B-Therapeutic_procedure
approach NN O
. . O

This DT O
operation NN O
had VBD O
significantly RB O
reduced VBN O
the DT O
frequency NN O
of IN O
her PRP$ O
symptoms NNS B-Sign_symptom
and CC O
for IN B-Duration
several JJ I-Duration
years NNS I-Duration
her PRP$ O
epistaxis NN B-Sign_symptom
was VBD O
under IN B-Lab_value
control NN I-Lab_value
with IN O
the DT O
use NN O
of IN O
low JJ B-Dosage
dose JJ I-Dosage
thalidomide NN B-Medication
. . O

However RB O
, , O
she PRP O
was VBD O
referred VBN O
to TO O
our PRP$ O
clinic NN B-Nonbiological_location
due JJ O
to TO O
increased VBN B-Detailed_description
epistaxis NN B-Sign_symptom
severity NN B-Severity
and CC O
frequency NN B-Frequency
over IN B-Duration
the DT I-Duration
prior JJ I-Duration
12 CD I-Duration
months NNS I-Duration
necessitating VBG O
more RBR O
frequent JJ O
transfusions NNS B-Therapeutic_procedure
. . O

At IN O
the DT O
time NN O
of IN O
consultation NN O
the DT O
patient NN O
was VBD O
concerned VBN O
about IN O
daily RB B-Frequency
severe JJ B-Severity
left NN B-Biological_structure
sided VBD I-Biological_structure
epistaxis JJ B-Sign_symptom
despite IN O
several JJ B-Duration
months NNS I-Duration
use IN O
of IN O
topical JJ O
bevacizumab NN B-Medication
and CC O
oral JJ O
tranexamic JJ B-Medication
acid NN I-Medication
. . O

She PRP O
required VBD O
intravenous JJ O
iron NN B-Medication
and CC O
blood NN B-Therapeutic_procedure
transfusions NNS I-Therapeutic_procedure
every DT B-Frequency
two CD I-Frequency
months NNS I-Frequency
. . O

Her PRP$ O
baseline NN O
hemoglobin NN B-Diagnostic_procedure
at IN O
the DT O
time NN O
of IN O
our PRP$ O
consultation NN O
was VBD O
75 CD B-Lab_value
g JJ I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
( ( O
normal JJ O
= $ O
120 CD O
- : O
160 CD O
g NN O
/ NNP O
L NNP O
) ) O
. . O

Her PRP$ O
HHT NNP B-Diagnostic_procedure
epistaxis NN I-Diagnostic_procedure
severity NN I-Diagnostic_procedure
score VBP I-Diagnostic_procedure
[ $ O
17 CD O
] NN O
was VBD O
severe JJ B-Lab_value
( ( O
normalized JJ B-Lab_value
score NN I-Lab_value
9 CD I-Lab_value
. . I-Lab_value
49 CD I-Lab_value
) ) O
. . O

On IN O
examination NN B-Diagnostic_procedure
, , O
she PRP O
had VBD O
multiple JJ B-Detailed_description
telangiectasia NN B-Sign_symptom
on IN O
her PRP$ O
fingers NNS B-Biological_structure
, , O
face NN B-Biological_structure
, , O
lips NNS B-Biological_structure
and CC O
palate NN B-Biological_structure
. . O

Her PRP$ O
endoscopic NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
bilateral JJ B-Detailed_description
telangiectasia NN B-Sign_symptom
along IN O
the DT O
nasal JJ B-Biological_structure
septum NN I-Biological_structure
. . O

There EX O
was VBD O
extensive JJ B-Severity
crusting NN B-Sign_symptom
along IN O
the DT O
entire JJ O
left NN B-Biological_structure
nasal NN I-Biological_structure
cavity NN I-Biological_structure
with IN O
which WDT O
any DT O
manipulation NN B-Diagnostic_procedure
resulted VBD O
in IN O
immediate JJ B-Detailed_description
profuse NN B-Severity
epistaxis NN B-Sign_symptom
. . O

Given VBN O
the DT O
severity NN O
of IN O
the DT O
patient NN O
` `` O
s JJ O
epistaxis NN O
despite IN O
medical JJ O
therapy NN O
, , O
she PRP O
was VBD O
offered VBN O
endoscopic NN B-Detailed_description
left VBD B-Detailed_description
- : I-Detailed_description
sided VBN I-Detailed_description
septodermoplasty NN B-Therapeutic_procedure
. . O

The DT O
surgical JJ O
goals NNS O
were VBD O
to TO O
improve VB O
her PRP$ O
quality NN O
of IN O
life NN O
by IN O
reducing VBG O
the DT O
number NN O
and CC O
severity NN O
of IN O
epistaxis JJ O
episodes NNS O
while IN O
diminishing VBG O
the DT O
need NN O
for IN O
blood NN O
transfusions NNS O
. . O

The DT O
patient NN O
was VBD O
content JJ O
with IN O
the DT O
treatment NN O
plan NN O
and CC O
agreed VBD O
to TO O
undergo VB O
surgical JJ O
intervention NN O
. . O

The DT O
endoscopic JJ B-Therapeutic_procedure
procedure NN I-Therapeutic_procedure
was VBD O
performed VBN O
under IN O
general JJ B-Medication
anesthesia NN I-Medication
with IN O
endotracheal JJ B-Detailed_description
intubation NN B-Therapeutic_procedure
. . O

The DT O
nasal JJ B-Biological_structure
cavity NN I-Biological_structure
was VBD O
prepared VBN B-Therapeutic_procedure
by IN O
inserting VBG B-Detailed_description
pledgets NNS I-Detailed_description
soaked VBN O
in IN O
topical JJ O
adrenaline NN B-Medication
( ( O
1:1000 CD B-Dosage
) ) O
placed VBN O
in IN O
both DT B-Biological_structure
nostrils NNS I-Biological_structure
for IN O
decongestion NN O
. . O

Using VBG B-Detailed_description
a DT I-Detailed_description
zero CD I-Detailed_description
degree NN I-Detailed_description
endoscope VBP I-Detailed_description
the DT O
residual JJ B-Biological_structure
STSG NNP I-Biological_structure
and CC I-Biological_structure
mucosa NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
left NN I-Biological_structure
septum NN I-Biological_structure
was VBD O
dissected VBN B-Therapeutic_procedure
in IN B-Detailed_description
a DT I-Detailed_description
supraperichondrial JJ I-Detailed_description
plane NN I-Detailed_description
that WDT O
resulted VBD O
in IN O
the DT O
expected JJ O
significant JJ B-Severity
diffuse NN B-Detailed_description
hemorrhage NN B-Sign_symptom
. . O

Immediate JJ B-Detailed_description
hemostasis NN B-Therapeutic_procedure
was VBD O
attained VBN O
using VBG O
a DT O
topical JJ B-Detailed_description
gelatin NN I-Detailed_description
- : I-Detailed_description
thrombin NN I-Detailed_description
matrix NN I-Detailed_description
, , O
Floseal NNP B-Detailed_description
( ( O
FloSeal NNP O
Hemostatic NNP O
Matrix NNP O
; : O
Baxter NNP O
Healthcare NNP O
Corporation NNP O
, , O
Deerfield NNP O
, , O
IL NNP O
, , O
USA NNP O
) ) O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
mucosal NN B-Sign_symptom
defect NN I-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
measured VBD O
approximately RB O
3 CD B-Distance
cm NNS I-Distance
in IN O
anterior JJ B-Detailed_description
- : I-Detailed_description
posterior JJ I-Detailed_description
dimension NN I-Detailed_description
. . O

A DT O
4 CD B-Area
x NN I-Area
2 CD I-Area
cm NN I-Area
split NN I-Area
thickness NN I-Area
skin NN B-Therapeutic_procedure
graft NN I-Therapeutic_procedure
was VBD I-Therapeutic_procedure
harvested VBN I-Therapeutic_procedure
from IN O
the DT O
right JJ B-Biological_structure
thigh NN I-Biological_structure
, , O
pie SYM B-Detailed_description
- : I-Detailed_description
crusted VBN I-Detailed_description
with IN I-Detailed_description
a DT I-Detailed_description
15 CD I-Detailed_description
blade NN I-Detailed_description
and CC O
then RB O
placed VBD B-Detailed_description
endoscopically RB I-Detailed_description
along IN B-Biological_structure
the DT I-Biological_structure
length NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
septal JJ I-Biological_structure
defect NN I-Biological_structure
. . O

As IN O
seen VBN O
in IN O
Fig NNP O
. . O
3 CD O
, , O
the DT O
graft NN O
was VBD O
placed VBN O
with IN O
an DT O
overlap NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
mucosa NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
nasal JJ I-Biological_structure
floor NN I-Biological_structure
and CC I-Biological_structure
the DT I-Biological_structure
residual JJ I-Biological_structure
superior JJ I-Biological_structure
septal JJ I-Biological_structure
mucosa NN I-Biological_structure
. . O

Finally RB O
, , O
2 CD B-Volume
mL NN I-Volume
of IN O
fibrin NN B-Detailed_description
sealant NN I-Detailed_description
( ( O
TISSEEL NNP O
fibrin RB O
sealant NN O
, , O
Baxter NNP O
Healthcare NNP O
Corporation NNP O
, , O
Deerfield NNP O
, , O
IL NNP O
, , O
USA NNP O
) ) O
was VBD O
then RB O
applied VBN B-Detailed_description
first RB I-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
edges NNS I-Detailed_description
then RB I-Detailed_description
central JJ I-Detailed_description
portion NN I-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
STSG NNP I-Detailed_description
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

Packing VBG B-Therapeutic_procedure
was VBD O
not RB O
used VBN O
post NN O
- : O
operatively RB O
and CC O
the DT O
patient NN O
was VBD O
discharged VBN O
home NN B-Nonbiological_location
on IN O
the DT O
same JJ O
day NN O
of IN O
surgery NN O
. . O

Clinical JJ O
follow NN O
- : O
up RB O
two CD O
weeks NNS O
after IN O
surgery NN O
( ( O
Fig NNP O
. . O
5 CD O
) ) O
showed VBD O
that IN O
the DT O
entire JJ O
graft NN B-Sign_symptom
had VBD I-Sign_symptom
taken VBN I-Sign_symptom
and CC O
the DT O
left JJ B-Detailed_description
- : I-Detailed_description
sided VBD I-Detailed_description
epistaxis NN B-Sign_symptom
had VBD O
dramatically RB O
diminished VBN O
. . O

The DT O
patient NN O
was VBD O
very RB O
content JJ O
with IN O
the DT O
results NNS O
of IN O
the DT O
procedure NN O
. . O

At IN O
6 CD O
months NNS O
follow VBP O
- : O
up RB O
, , O
her PRP O
baseline NN O
hemoglobin NN B-Diagnostic_procedure
had VBD O
improved VBN O
to TO O
102 CD B-Lab_value
g NNS I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
and CC O
she PRP O
was VBD O
requiring VBG O
transfusions NNS B-Therapeutic_procedure
every DT B-Frequency
4 CD I-Frequency
months NNS I-Frequency
with IN O
her PRP$ O
hematologist NN O
` `` O
s JJ O
intent NN O
to TO O
stop VB O
the DT O
transfusions NNS O
if IN O
her PRP$ O
hemoglobin NN O
remained VBD O
greater JJR O
than IN O
100 CD O
g JJ O
/ NNP O
L NNP O
. . O

Her PRP$ O
epistaxis JJ B-Diagnostic_procedure
severity NN I-Diagnostic_procedure
score NN I-Diagnostic_procedure
at IN O
6 CD O
month NN O
follow VBD O
up RP O
was VBD O
mild JJ B-Lab_value
( ( O
normalized VBN B-Lab_value
score RB I-Lab_value
3 CD I-Lab_value
. . I-Lab_value
05 CD I-Lab_value
) ) O
. . O

-DOCSTART- NN -X-

A DT O
45 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
lady NN O
sought VBD O
dermatology NN O
consultation NN O
for IN O
severely RB B-Texture
tender NN I-Texture
erythematous JJ B-Detailed_description
vesicles NNS B-Sign_symptom
and CC O
bullae NN B-Sign_symptom
over IN O
back RB B-Biological_structure
, , O
chest NN B-Biological_structure
and CC O
arms NNS B-Biological_structure
. . O

These DT O
were VBD O
sudden JJ B-Detailed_description
in IN I-Detailed_description
onset NN I-Detailed_description
associated VBN O
with IN O
fever NN B-Sign_symptom
, , O
nausea NN B-Sign_symptom
and CC O
malaise NN B-Sign_symptom
. . O

Along IN O
with IN O
this DT O
she PRP O
also RB O
complained VBD O
of IN O
pain NN B-Sign_symptom
in IN O
upper JJ B-Biological_structure
abdomen NNS I-Biological_structure
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
receiving VBG O
any DT O
drugs NNS B-Medication
prior RB B-Time
to TO I-Time
the DT I-Time
onset NN I-Time
of IN I-Time
lesions NNS I-Time
. . O

She PRP O
did VBD O
not RB O
report VB O
any DT O
significant JJ B-Detailed_description
weight JJ B-Sign_symptom
loss NN I-Sign_symptom
or CC O
loss NN B-Sign_symptom
of IN I-Sign_symptom
appetite NN I-Sign_symptom
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
her PRP$ O
temperature NN B-Diagnostic_procedure
was VBD O
38 CD B-Lab_value
°C NN I-Lab_value
, , O
pulse JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
100 CD B-Lab_value
/ JJ I-Lab_value
min NN I-Lab_value
and CC O
blood NN B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
was VBD O
126 CD B-Lab_value
/ JJ I-Lab_value
72 CD I-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
. . O

There EX O
were VBD O
multiple JJ B-Lab_value
coalescing NN B-Detailed_description
vesicles NNS O
and CC O
bullae NN O
over IN O
upper JJ B-Biological_structure
back RB I-Biological_structure
, , O
chest NN B-Biological_structure
and CC O
arms NNS B-Biological_structure
distributed VBN B-Detailed_description
symmetrically RB I-Detailed_description
showing VBG O
areas NNS O
of IN O
pustulation NN B-Sign_symptom
and CC O
necrosis NN B-Sign_symptom
. . O

Surrounding VBG B-Other_entity
them PRP O
were VBD O
multiple JJ B-Lab_value
pseudovesicular JJ B-Detailed_description
satellite NN B-Detailed_description
papule NN B-Sign_symptom
( ( O
figure NN O
1A CD O
, , O
B NNP O
) ) O
. . O

On IN O
per IN O
abdominal JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
mild NN B-Severity
tenderness NN B-Sign_symptom
was VBD O
present JJ O
in IN O
the DT O
right JJ B-Biological_structure
hypochondrium NN I-Biological_structure
. . O

Patient NNP O
` `` O
s JJ O
initial JJ O
laboratory NN B-Diagnostic_procedure
investigations NNS I-Diagnostic_procedure
showed VBD O
a DT O
total JJ B-Diagnostic_procedure
leucocyte NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
of IN O
12 CD B-Lab_value
000 CD I-Lab_value
cells NNS I-Lab_value
/ JJ I-Lab_value
mm3 NN I-Lab_value
with IN O
75 CD B-Lab_value
% NN I-Lab_value
neutrophils NNS I-Lab_value
. . O

The DT O
haemoglobin NN B-Diagnostic_procedure
level NN O
was VBD O
14 CD B-Lab_value
. . I-Lab_value
3 CD I-Lab_value
gm NN I-Lab_value
% NN I-Lab_value
and CC O
erythrocyte JJ B-Diagnostic_procedure
sedimentation NN I-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
30 CD B-Lab_value
mm NN I-Lab_value
/ NN I-Lab_value
h NN I-Lab_value
. . O

Liver NNP B-Diagnostic_procedure
function NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
, , O
kidney NN B-Diagnostic_procedure
function NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
and CC O
C NNP B-Diagnostic_procedure
reactive VBP I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
levels NNS O
were VBD O
within IN O
normal JJ B-Lab_value
limits NNS O
. . O

Gram NNP B-Diagnostic_procedure
stain NN I-Diagnostic_procedure
from IN O
purulent NN B-Diagnostic_procedure
exudates NNS I-Diagnostic_procedure
showed VBD O
only RB O
neutrophils RB B-Biological_structure
without IN O
any DT O
organisms NNS B-Sign_symptom
and CC O
culture NN B-Diagnostic_procedure
did VBD O
not RB O
show VB O
any DT O
growth NN B-Sign_symptom
after IN O
72 CD B-Duration
h NN I-Duration
of IN I-Duration
incubation NN I-Duration
. . O

A DT O
lesional JJ B-Detailed_description
skin NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
taken VBN O
from IN O
the DT O
satellite NN B-Detailed_description
papule NN O
showed VBD O
neutrophilic JJ B-Sign_symptom
infiltration NN I-Sign_symptom
in IN O
dermis NN B-Biological_structure
with IN O
papillary JJ B-Sign_symptom
dermal JJ I-Sign_symptom
oedema NN I-Sign_symptom
and CC O
spongiosis NN B-Sign_symptom
( ( O
figure NN O
2A CD O
, , O
B NNP O
) ) O
. . O

Abdominal NNP B-Biological_structure
ultrasonography NN B-Diagnostic_procedure
revealed VBD O
intraluminal JJ B-Detailed_description
gall NN B-Biological_structure
bladder NN I-Biological_structure
mass NN B-Sign_symptom
suggestive NN O
of IN O
malignancy NN B-Sign_symptom
. . O

On IN O
the DT O
basis NN O
of IN O
these DT O
findings NNS O
a DT O
final JJ O
diagnosis NN O
of IN O
SS NNP B-Disease_disorder
associated VBN O
with IN O
gall JJ O
bladder NN O
malignancy NN O
was VBD O
made VBN O
. . O

She PRP O
was VBD O
started VBN O
on IN O
oral JJ O
prednisolone NN B-Medication
in IN O
dose NN O
of IN O
40 CD B-Dosage
mg JJ I-Dosage
daily RB B-Frequency
along IN O
with IN O
symptomatic JJ B-Detailed_description
treatment NN B-Medication
. . O

Her PRP$ O
cutaneous JJ B-Detailed_description
lesions NNS B-Sign_symptom
responded VBD O
dramatically RB O
and CC O
subsided VBD B-Detailed_description
completely RB I-Detailed_description
after IN O
1 CD B-Duration
week NN I-Duration
of IN O
treatment NN B-Medication
( ( O
figure NN O
3A CD O
, , O
B NNP O
) ) O
. . O

Dose NNP O
of IN O
prednisolone NN O
was VBD O
tapered VBN O
and CC O
an DT O
open JJ B-Detailed_description
cholecystectomy NN B-Therapeutic_procedure
was VBD O
performed VBN O
. . O

Histopathology NNP B-Diagnostic_procedure
of IN O
excised JJ B-Biological_structure
tissue NN I-Biological_structure
confirmed VBD O
it PRP O
to TO O
be VB O
well RB B-Detailed_description
- : I-Detailed_description
differentiated VBN I-Detailed_description
gall JJ B-Biological_structure
bladder NN I-Biological_structure
adenocarcinoma NN B-Disease_disorder
forming VBG O
glands NNS B-Sign_symptom
and CC I-Sign_symptom
papillae NN B-Biological_structure
infiltrating VBG B-Sign_symptom
the DT I-Sign_symptom
muscularis NN B-Biological_structure
propria NN I-Biological_structure
superficially RB B-Detailed_description
. . O

Cystic JJ B-Biological_structure
duct NN I-Biological_structure
cut NN I-Biological_structure
margins NNS I-Biological_structure
were VBD O
free JJ O
of IN O
tumour NN B-Sign_symptom
( ( O
figure NN O
2C CD O
, , O
D NNP O
) ) O
. . O

Patient NNP O
` `` O
s RB O
postoperative JJ B-Duration
period NN I-Duration
was VBD O
uneventful JJ B-Sign_symptom
and CC O
she PRP O
was VBD O
discharged VBN O
on IN O
tapering VBG B-Dosage
doses NNS I-Dosage
of IN O
prednisolone NN O
with IN O
advice NN O
to TO O
follow VB O
- : O
up RB O
periodically RB O
. . O

-DOCSTART- NN -X-

A DT O
44 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
had VBD O
been VBN O
diagnosed VBN O
with IN O
LCNEC NNP B-Disease_disorder
of IN O
the DT O
thymus NN B-Biological_structure
with IN O
bone NN B-Biological_structure
metastasis NN B-Sign_symptom
at IN O
a DT O
different JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
3 CD O
years NNS O
previously RB O
. . O

The DT O
serum NN O
levels NNS O
of IN O
ACTH NNP B-Diagnostic_procedure
and CC O
cortisol NN B-Diagnostic_procedure
were VBD O
elevated VBN B-Lab_value
, , O
but CC O
brain NN B-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
revealed VBD O
that IN O
his PRP$ O
pituitary JJ B-Detailed_description
gland NN I-Detailed_description
was VBD O
normal JJ B-Lab_value
. . O

However RB O
, , O
immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
of IN O
the DT O
thymic JJ B-Biological_structure
tumor NN I-Biological_structure
tissue NN I-Biological_structure
revealed VBD O
partial JJ B-Lab_value
anti NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
ACTH NNP I-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
positivity NN B-Lab_value
. . O

The DT O
tumor NN O
was VBD O
therefore RB O
determined VBN O
to TO O
be VB O
ectopically RB B-Detailed_description
producing VBG I-Detailed_description
ACTH NNP I-Detailed_description
. . O

The DT O
patient JJ O
underwent JJ O
chemotherapy NN B-Medication
with IN O
cisplatin NN B-Medication
and CC O
irinotecan JJ B-Medication
, , O
but CC O
the DT O
continuation NN O
of IN O
chemotherapy NN O
was VBD O
problematic JJ B-Detailed_description
due JJ I-Detailed_description
to TO I-Detailed_description
a DT I-Detailed_description
lack NN I-Detailed_description
of IN I-Detailed_description
tolerance NN I-Detailed_description
. . O

Treatment NN O
for IN O
hypertension NN B-Sign_symptom
and CC O
diabetes NNS B-Disease_disorder
caused VBN O
by IN O
the DT O
ectopic NN B-Disease_disorder
ACTH NNP I-Disease_disorder
syndrome NN I-Disease_disorder
was VBD O
initiated VBN O
, , O
as IN O
was VBD O
treatment NN O
with IN O
zoledronic JJ B-Medication
acid NN I-Medication
for IN O
bone NN B-Biological_structure
metastasis NN B-Sign_symptom
. . O

The DT O
patient NN O
was VBD O
referred VBN O
to TO O
the DT O
Endocrine NNP B-Nonbiological_location
Center NNP I-Nonbiological_location
at IN I-Nonbiological_location
our PRP$ I-Nonbiological_location
hospital NN I-Nonbiological_location
after IN O
3 CD O
months NNS O
due JJ O
to TO O
a DT O
sensation NN B-Sign_symptom
of IN I-Sign_symptom
weakness NN I-Sign_symptom
and CC O
the DT O
worsening NN O
of IN O
his PRP$ O
hyperglycemia NN B-Sign_symptom
. . O

A DT O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
hypertension NN B-Sign_symptom
, , O
a DT O
subcutaneous JJ B-Detailed_description
mass NN B-Sign_symptom
that WDT O
was VBD O
palpable JJ B-Detailed_description
in IN O
the DT O
anterior JJ B-Biological_structure
chest NN I-Biological_structure
, , O
and CC O
redness NN B-Sign_symptom
and CC O
swelling NN B-Sign_symptom
of IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
leg NN I-Biological_structure
without IN O
fever NN B-Sign_symptom
, , O
respiratory NN B-Sign_symptom
symptoms NNS I-Sign_symptom
, , O
hypoxemia NN B-Sign_symptom
, , O
or CC O
abnormal JJ B-Sign_symptom
chest NN I-Sign_symptom
sounds NNS I-Sign_symptom
. . O

The DT O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
by IN O
pulse JJ B-Detailed_description
oximeter NN I-Detailed_description
in IN O
room NN B-Detailed_description
air NN I-Detailed_description
and CC O
was VBD O
97 CD B-Lab_value
% NN I-Lab_value
and CC O
his PRP$ O
respiratory NN B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
was VBD O
13 CD B-Lab_value
breaths NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
. . O

Among IN O
the DT O
laboratory NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
, , O
the DT O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
and CC O
neutrophil JJ B-Diagnostic_procedure
counts NNS O
, , O
and CC O
blood NN B-Diagnostic_procedure
sugar NN I-Diagnostic_procedure
, , O
triglyceride NN B-Diagnostic_procedure
, , O
and CC O
low JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
density NN I-Diagnostic_procedure
lipoprotein VBP I-Diagnostic_procedure
cholesterol NN I-Diagnostic_procedure
levels NNS O
were VBD O
found VBN O
to TO O
be VB O
elevated VBN B-Lab_value
, , O
and CC O
the DT O
patient NN O
` `` O
s JJ O
potassium NN B-Diagnostic_procedure
level NN O
was VBD O
decreased VBN B-Lab_value
to TO O
2 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mEq JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
. . O

The DT O
patient NN O
` `` O
s JJ O
lactate NN B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
( ( O
468 CD B-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
) ) O
, , O
beta SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
D JJ I-Diagnostic_procedure
glucan JJ I-Diagnostic_procedure
( ( O
370 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
, , O
ACTH NNP B-Diagnostic_procedure
( ( O
354 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
pg JJ I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
, , O
and CC O
cortisol NN B-Diagnostic_procedure
( ( O
49 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
levels NNS O
were VBD O
also RB O
elevated VBN B-Lab_value
. . O

The DT O
patient NN O
` `` O
s JJ O
serum NN B-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
for IN O
aspergillus NN B-Diagnostic_procedure
, , O
candida NN B-Diagnostic_procedure
, , O
and CC O
cryptococcus NN B-Diagnostic_procedure
antigens NNS I-Diagnostic_procedure
; : O
a DT O
cytomegalovirus NN B-Diagnostic_procedure
pp65 NN I-Diagnostic_procedure
antigenemia NN I-Diagnostic_procedure
test NN I-Diagnostic_procedure
also RB O
yielded VBD O
a DT O
negative JJ B-Lab_value
result NN O
. . O

These DT O
data NNS O
suggested VBD O
that IN O
the DT O
increased JJ O
production NN O
of IN O
ACTH NNP O
by IN O
the DT O
tumor NN O
, , O
along IN O
with IN O
the DT O
progression NN O
of IN O
the DT O
disease NN O
, , O
had VBD O
promoted VBN O
the DT O
elevation NN O
of IN O
the DT O
patient NN O
` `` O
s JJ O
serum NN O
levels NNS O
of IN O
ACTH NNP O
and CC O
cortisol NN O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
revealed VBD O
the DT O
progression NN B-Sign_symptom
of IN I-Sign_symptom
the DT I-Sign_symptom
disease NN I-Sign_symptom
in IN O
the DT O
both DT O
thymic JJ B-Biological_structure
and CC O
metastatic JJ B-Detailed_description
bone NN B-Biological_structure
lesions NNS B-Sign_symptom
, , O
along IN O
with IN O
the DT O
multiple NN B-Detailed_description
ground NN B-Texture
- : I-Texture
glass NN I-Texture
opacities NNS B-Sign_symptom
in IN O
both DT B-Biological_structure
lungs NNS I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
, , O
2 CD O
) ) O
. . O

The DT O
patient JJ O
underwent JJ O
bronchoalveolar JJ B-Diagnostic_procedure
lavage NN I-Diagnostic_procedure
( ( O
BAL NNP B-Diagnostic_procedure
) ) O
in IN O
the DT O
right JJ B-Biological_structure
B5 NNP I-Biological_structure
segment NN I-Biological_structure
with IN O
150 CD B-Detailed_description
mL NNS I-Detailed_description
saline NN I-Detailed_description
, , O
and CC O
62 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
% NN I-Lab_value
of IN I-Lab_value
the DT I-Lab_value
BAL NNP I-Lab_value
fluid NN I-Lab_value
was VBD I-Lab_value
recovered VBN I-Lab_value
. . O

The DT O
cell NN B-Diagnostic_procedure
count NN I-Diagnostic_procedure
in IN O
the DT O
BAL NNP B-Detailed_description
fluid NN I-Detailed_description
was VBD O
0 CD B-Lab_value
. . I-Lab_value
61 CD I-Lab_value
× JJ I-Lab_value
105 CD I-Lab_value
per IN I-Lab_value
mL NN I-Lab_value
, , O
and CC O
the DT O
cell NN B-Diagnostic_procedure
differentiation NN I-Diagnostic_procedure
in IN O
the DT O
BAL NNP B-Detailed_description
fluid NN I-Detailed_description
was VBD O
17 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
% NN I-Lab_value
macrophages NNS I-Lab_value
, , O
81 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
% NN I-Lab_value
lymphocytes NNS I-Lab_value
, , O
and CC O
2 CD B-Lab_value
. . I-Lab_value
0 CD I-Lab_value
% NN I-Lab_value
neutrophils NNS I-Lab_value
, , O
with IN O
a DT O
CD NN B-Lab_value
4 CD I-Lab_value
/ NN I-Lab_value
8 CD I-Lab_value
ratio NN I-Lab_value
of IN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
57 CD I-Lab_value
. . O

Gram NNP B-Diagnostic_procedure
, , O
Ziehl NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Neelsen NNP I-Diagnostic_procedure
, , O
and CC O
Grocott NNP B-Diagnostic_procedure
staining VBG I-Diagnostic_procedure
were VBD O
all DT O
negative JJ B-Lab_value
. . O

A DT O
polymerase NN B-Diagnostic_procedure
chain NN I-Diagnostic_procedure
reaction NN I-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
patient NN O
` `` O
s JJ O
BAL NNP B-Detailed_description
fluid NN I-Detailed_description
was VBD O
positive JJ B-Lab_value
for IN O
Pneumocystis NNP B-Diagnostic_procedure
jirovecii NN I-Diagnostic_procedure
. . O

PCP NNP B-Disease_disorder
was VBD O
diagnosed VBN O
based VBN O
on IN O
the DT O
above JJ O
results NNS O
. . O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
sulfamethoxazole JJ B-Medication
/ NN I-Medication
trimethoprim NN I-Medication
( ( O
12 CD B-Dosage
g NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
) ) O
for IN O
3 CD B-Duration
weeks NNS I-Duration
. . O

Anti NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
cortisol NN I-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
with IN O
metyrapone NN B-Medication
was VBD O
also RB O
initiated VBN O
at IN O
the DT O
same JJ O
time NN O
with IN O
a DT O
small JJ B-Dosage
dose NN I-Dosage
to TO O
slowly VB O
correct VB O
the DT O
hypercortisolemia NN B-Disease_disorder
. . O

Intensive JJ O
insulin NN B-Medication
therapy NN O
, , O
potassium NN B-Medication
supplementation NN O
were VBD O
initiated VBN O
, , O
while IN O
cefazolin NN B-Medication
was VBD O
administered VBN O
to TO O
treat VB O
cellulitis NN B-Disease_disorder
of IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
leg NN I-Biological_structure
. . O

The DT O
patient NN O
` `` O
s JJ O
PCP NNP B-Disease_disorder
fully RB O
improved VBD O
without IN O
the DT O
exacerbation NN B-Sign_symptom
of IN O
his PRP$ O
respiratory NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
. . O

Thereafter RB O
, , O
we PRP O
continued VBD O
to TO O
administer VB O
sulfamethoxazole JJ B-Medication
/ NN I-Medication
trimethoprim NN I-Medication
at IN O
a DT O
prophylactic JJ B-Dosage
dose NN I-Dosage
. . O

The DT O
metyrapone NN B-Medication
dosage NN O
was VBD O
gradually RB O
increased VBN O
from IN O
250 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
, , O
and CC O
the DT O
blood NN B-Diagnostic_procedure
cortisol NN I-Diagnostic_procedure
value NN O
was VBD O
observed VBN O
to TO O
decline VB B-Lab_value
slowly RB I-Lab_value
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

In IN O
order NN O
to TO O
prevent VB O
hypocortisolemia NN O
, , O
the DT O
patient NN O
was VBD O
temporarily RB B-Detailed_description
treated VBN O
with IN O
hydrocortisone NN B-Medication
. . O

After IN O
an DT O
improvement NN O
of IN O
his PRP$ O
left JJ B-Biological_structure
lower JJR I-Biological_structure
leg NN I-Biological_structure
cellulitis NN B-Disease_disorder
, , O
PCP NNP B-Disease_disorder
, , O
and CC O
hyperglycemia NN B-Disease_disorder
, , O
the DT O
patient JJ O
underwent JJ O
laminectomy NN B-Therapeutic_procedure
and CC O
radiation NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
for IN O
spinal JJ B-Disease_disorder
cord NN I-Disease_disorder
compression NN I-Disease_disorder
, , O
which WDT O
had VBD O
been VBN O
caused VBN O
by IN O
a DT O
metastatic JJ B-Detailed_description
spinal JJ B-Biological_structure
tumor NN B-Sign_symptom
. . O

Octreotide NNP B-Medication
therapy NN O
was VBD O
initiated VBN O
, , O
and CC O
he PRP O
was VBD O
discharged VBN O
on IN O
the DT O
68th JJ O
day NN O
of IN O
hospitalization NN O
. . O

-DOCSTART- NN -X-

Our PRP$ O
patient NN O
was VBD O
a DT O
7 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Italian JJ O
boy NN O
born VBN O
after IN O
an DT O
uneventful JJ O
gestation NN O
of IN O
normal JJ O
duration NN O
. . O

At IN O
the DT O
age NN O
of IN O
16 CD O
months NNS O
, , O
he PRP O
presented VBD O
with IN O
a DT O
clinically RB B-Detailed_description
evident JJ I-Detailed_description
enlarged VBN B-Sign_symptom
abdomen NNS B-Biological_structure
and CC O
was VBD O
referred VBN O
for IN O
oncological JJ B-Nonbiological_location
examination NN I-Nonbiological_location
. . O

Initial JJ O
tests NNS O
revealed VBD O
anemia NN B-Sign_symptom
, , O
thrombocytopenia NN B-Sign_symptom
, , O
and CC O
splenomegaly NN B-Sign_symptom
. . O

A DT O
bone NN B-Biological_structure
marrow NN I-Biological_structure
biopsy NN B-Diagnostic_procedure
revealed VBD O
the DT O
presence NN O
of IN O
foam NN B-Sign_symptom
cells NNS I-Sign_symptom
, , O
which WDT O
led VBD O
to TO O
suspicion NN O
of IN O
lysosomal JJ B-Disease_disorder
storage NN I-Disease_disorder
disease NN I-Disease_disorder
. . O

Biochemical JJ B-Diagnostic_procedure
testing VBG I-Diagnostic_procedure
revealed VBN O
elevated JJ B-Lab_value
level NN O
of IN O
acid JJ B-Diagnostic_procedure
phosphatase NN I-Diagnostic_procedure
( ( O
47 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
IU NNP I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
[ NNP O
normal JJ O
range NN O
5 CD O
- : O
7 CD O
IU NNP O
/ NNP O
L NNP O
] NNP O
) ) O
and CC O
chitotriosidase NN B-Diagnostic_procedure
activity NN I-Diagnostic_procedure
( ( O
508 CD B-Lab_value
nmol RB I-Lab_value
/ JJ I-Lab_value
mg NN I-Lab_value
protein NN I-Lab_value
[ NNP O
normal JJ O
range NN O
5 CD O
. . O
9 CD O
- : O
41 CD O
. . O
0 CD O
nmol JJ O
/ NNP O
mg NN O
protein NN O
] NNP O
) ) O
, , O
as RB O
well RB O
as IN O
reduced VBN B-Lab_value
beta IN B-Diagnostic_procedure
- : I-Diagnostic_procedure
glucosidase NN I-Diagnostic_procedure
activity NN I-Diagnostic_procedure
( ( O
2 CD B-Lab_value
nmol RB I-Lab_value
/ JJ I-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
protein NN I-Lab_value
[ NNP O
normal JJ O
range NN O
4 CD O
. . O
5 CD O
- : O
18 CD O
. . O
0 CD O
nmol JJ O
/ NNP O
mg NN O
/ NNP O
protein NN O
] NN O
) ) O
. . O

Molecular JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
homozygous JJ B-Detailed_description
L444P NNP B-Detailed_description
mutations NNS B-Sign_symptom
in IN I-Sign_symptom
the DT I-Sign_symptom
GBA NNP I-Sign_symptom
gene NN I-Sign_symptom
( ( O
OMIM NNP O
reference RB O
606463 CD O
) ) O
, , O
confirming VBG O
the DT O
diagnosis NN O
of IN O
chronic JJ O
NGD NNP B-Disease_disorder
. . O

The DT O
patient NN O
began VBD O
ERT NNP B-Therapeutic_procedure
at IN O
a DT O
dosage NN O
of IN O
60 CD B-Dosage
U NNP I-Dosage
/ NNP I-Dosage
kg VBD I-Dosage
every DT I-Dosage
2 CD I-Dosage
weeks NNS I-Dosage
at IN O
the DT O
age NN O
of IN O
18 CD O
months NNS O
. . O

Thereafter RB O
, , O
when WRB O
the DT O
patient NN O
reached VBD O
the DT O
age NN O
of IN O
30 CD O
months NNS O
, , O
we PRP O
decided VBD O
to TO O
combine VB O
ERT NNP B-Therapeutic_procedure
with IN O
SRT NNP B-Therapeutic_procedure
with IN O
miglustat NN B-Medication
. . O

This DT O
clinical JJ O
decision NN O
was VBD O
approved VBN O
by IN O
our PRP$ O
institution NN O
` `` O
s JJ O
ethics NNS O
committee NN O
, , O
and CC O
informed VBD O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
` `` O
s JJ O
parents NNS O
before IN O
commencing VBG O
combination NN O
therapy NN O
. . O

The DT O
dose NN O
of IN O
miglustat NN B-Medication
was VBD O
adjusted VBN B-Detailed_description
according VBG I-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
patient NN I-Detailed_description
` `` I-Detailed_description
s JJ I-Detailed_description
body NN I-Detailed_description
surface JJ I-Detailed_description
area NN I-Detailed_description
and CC O
was VBD O
uptitrated VBN O
during IN O
the DT O
first JJ O
4 CD O
weeks NNS O
with IN O
the DT O
following JJ O
scheme NN O
: : O
one CD O
- : O
third NN O
of IN O
target NN O
dose NN O
during IN O
weeks NNS O
1 CD O
and CC O
2 CD O
, , O
two CD O
- : O
thirds NNS O
of IN O
target NN O
dose NN O
during IN O
weeks NNS O
3 CD O
and CC O
4 CD O
, , O
and CC O
target NN O
dose NN O
( ( O
100 CD B-Dosage
mg NN I-Dosage
three CD I-Dosage
times NNS I-Dosage
daily RB I-Dosage
) ) O
after IN O
1 CD O
month NN O
. . O

From IN O
2 CD O
weeks NNS O
before IN O
starting VBG O
miglustat JJ B-Medication
therapy NN O
, , O
the DT O
patient NN O
also RB O
followed VBD O
specific JJ O
dietary JJ B-Therapeutic_procedure
modifications NNS I-Therapeutic_procedure
, , O
avoiding VBG B-Detailed_description
high JJ I-Detailed_description
intake NN I-Detailed_description
of IN I-Detailed_description
carbohydrate NN I-Detailed_description
- : I-Detailed_description
containing VBG I-Detailed_description
food NN I-Detailed_description
in IN I-Detailed_description
single JJ I-Detailed_description
meals NNS I-Detailed_description
, , O
especially RB O
foods NNS B-Detailed_description
high JJ I-Detailed_description
in IN I-Detailed_description
disaccharides NNS I-Detailed_description
, , I-Detailed_description
such JJ I-Detailed_description
as IN I-Detailed_description
sucrose JJ I-Detailed_description
and CC I-Detailed_description
maltose JJ I-Detailed_description
, , O
to TO O
ensure VB O
acceptable JJ O
gastrointestinal JJ O
tolerability NN O
. . O

He PRP O
experienced VBD O
mild JJ B-Severity
episodes NNS O
of IN O
diarrhea NN B-Sign_symptom
after IN O
commencing VBG O
miglustat JJ B-Medication
therapy NN O
, , O
which WDT O
decreased VBD B-Lab_value
in IN I-Lab_value
frequency NN I-Lab_value
/ NNP I-Lab_value
severity NN I-Lab_value
over IN I-Lab_value
time NN I-Lab_value
. . O

From IN O
the DT O
start NN O
of IN O
ERT NNP O
/ NNP O
miglustat POS O
combination NN O
treatment NN O
, , O
we PRP O
observed VBD O
a DT O
reduction NN O
in IN O
splenomegaly NN B-Sign_symptom
and CC O
a DT O
gradual JJ O
normalization NN B-Lab_value
of IN O
hematological JJ B-Diagnostic_procedure
values NNS I-Diagnostic_procedure
and CC O
plasma NN B-Diagnostic_procedure
angiotensin SYM I-Diagnostic_procedure
- : I-Diagnostic_procedure
converting VBG I-Diagnostic_procedure
enzyme JJ I-Diagnostic_procedure
activity NN I-Diagnostic_procedure
( ( O
Table JJ O
1 CD O
) ) O
. . O

Plasma NNP B-Diagnostic_procedure
chitotriosidase NN I-Diagnostic_procedure
was VBD O
evaluated VBN O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
and CC O
then RB O
approximately RB O
every DT B-Frequency
6 CD I-Frequency
months NNS I-Frequency
during IN O
follow JJ O
- : O
up RB O
. . O

Values NNS O
showed VBD O
an DT O
initial JJ B-Lab_value
reduction NN I-Lab_value
after IN B-Detailed_description
the DT I-Detailed_description
start NN I-Detailed_description
of IN I-Detailed_description
ERT NNP I-Detailed_description
, , O
with IN O
a DT O
further JJ O
, , O
substantial JJ O
, , O
and CC O
sustained VBD B-Lab_value
decrease NN I-Lab_value
after IN B-Detailed_description
commencement NN I-Detailed_description
of IN I-Detailed_description
miglustat NN I-Detailed_description
treatment NN O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

The DT O
patient NN O
has VBZ O
been VBN O
followed VBN O
according VBG B-Detailed_description
to TO I-Detailed_description
recommended VBN I-Detailed_description
guidelines NNS I-Detailed_description
for IN I-Detailed_description
GD NNP I-Detailed_description
, , O
which WDT O
specify VBP O
a DT O
complete JJ O
neurological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
clinical JJ O
evaluation NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
ocular JJ I-Diagnostic_procedure
movements NNS I-Diagnostic_procedure
, , O
and CC O
psychological JJ B-Diagnostic_procedure
evaluations NNS I-Diagnostic_procedure
every DT B-Frequency
6 CD I-Frequency
- : I-Frequency
12 CD I-Frequency
months NNS I-Frequency
[ RB O
10 CD O
] NNS O
. . O

After IN O
5 CD B-Duration
years NNS I-Duration
of IN O
combination NN B-Therapeutic_procedure
therapy NN I-Therapeutic_procedure
and CC O
follow VB O
- : O
up RB O
, , O
the DT O
patient NN O
did VBD O
not RB O
show VB O
any DT O
signs NNS O
of IN O
neurological JJ B-Sign_symptom
impairment NN I-Sign_symptom
. . O

As IN O
of IN O
February NNP O
2016 CD O
, , O
he PRP O
had VBD O
not RB O
displayed VBN O
any DT O
epileptic JJ B-Sign_symptom
crises NNS I-Sign_symptom
and CC O
had VBD O
demonstrated VBN O
clinical JJ B-Sign_symptom
performance NN I-Sign_symptom
and CC O
cooperation NN B-Activity
. . O

He PRP O
showed VBD O
good JJ B-Lab_value
muscular JJ B-Diagnostic_procedure
tone NN I-Diagnostic_procedure
and CC I-Diagnostic_procedure
trophism NN I-Diagnostic_procedure
, , O
normal JJ B-Lab_value
reflexes NNS B-Diagnostic_procedure
with IN O
a DT O
slight JJ B-Severity
hyperreflexia NN B-Sign_symptom
in IN O
his PRP$ O
legs NN B-Biological_structure
, , O
and CC O
a DT O
negative JJ B-Lab_value
Romberg NNP B-Diagnostic_procedure
sign NN I-Diagnostic_procedure
. . O

His PRP$ O
toe NN B-Diagnostic_procedure
and CC I-Diagnostic_procedure
heel NN I-Diagnostic_procedure
deambulation NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

In IN O
particular JJ O
, , O
ocular JJ B-Diagnostic_procedure
evaluations NNS I-Diagnostic_procedure
revealed VBD O
no DT O
evidence NN O
of IN O
saccadic JJ B-Sign_symptom
movement NN I-Sign_symptom
velocity NN I-Sign_symptom
reduction NN I-Sign_symptom
and CC O
normal JJ B-Lab_value
visual JJ B-Diagnostic_procedure
evoked VBN I-Diagnostic_procedure
potentials NNS I-Diagnostic_procedure
. . O

The DT O
patient NN O
` `` O
s JJ O
auditory NN B-Diagnostic_procedure
brain NN I-Diagnostic_procedure
responses NNS I-Diagnostic_procedure
were VBD O
also RB O
normal JJ B-Lab_value
. . O

In IN O
addition NN O
, , O
he PRP O
has VBZ O
not RB O
demonstrated VBN O
any DT O
cognitive JJ B-Sign_symptom
impairment NN I-Sign_symptom
, , O
and CC O
he PRP O
has VBZ O
regularly RB B-Detailed_description
attended VBN B-Activity
school NN I-Activity
with IN O
good JJ B-Detailed_description
performance NN I-Detailed_description
since IN O
the DT O
age NN O
of IN O
5 CD O
years NNS O
. . O

-DOCSTART- NN -X-

An DT O
84 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
presented VBD O
to TO O
a DT O
local JJ B-Nonbiological_location
clinic NN I-Nonbiological_location
with IN O
dyspnea NN B-Sign_symptom
on IN B-Detailed_description
exertion NN I-Detailed_description
and CC O
left VBD B-Biological_structure
back RP I-Biological_structure
pain NN B-Sign_symptom
persisting NN B-Duration
for IN I-Duration
a DT I-Duration
month NN I-Duration
. . O

She PRP O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
because IN O
of IN O
left JJ B-Detailed_description
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
on IN O
a DT O
chest NN B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
. . O

She PRP O
suffered VBD O
hypertension NN O
and CC O
dyslipidemia NN O
but CC O
had VBD O
no DT O
history NN O
of IN O
pleural JJ O
tuberculosis NN O
or CC O
chronic JJ O
pyothorax NN O
, , O
nor CC O
a DT O
smoking NN O
history NN O
or CC O
dust NN O
exposure NN O
. . O

On IN O
examination NN B-Diagnostic_procedure
, , O
her PRP$ O
vital JJ B-Diagnostic_procedure
signs NNS I-Diagnostic_procedure
and CC O
oxygen NN B-Diagnostic_procedure
saturation NN I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
( ( O
SpO2 NNP B-Diagnostic_procedure
: : O
96 CD B-Lab_value
% NN I-Lab_value
ambient JJ B-Detailed_description
air NN I-Detailed_description
) ) O
. . O

A DT O
chest JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
a DT O
mass NN B-Sign_symptom
on IN O
the DT O
left JJ B-Biological_structure
side NN I-Biological_structure
of IN I-Biological_structure
her PRP$ I-Biological_structure
back NN I-Biological_structure
with IN O
pain NN B-Sign_symptom
and CC O
decreased VBD B-Sign_symptom
breathing VBG I-Sign_symptom
sounds NNS I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
lower JJR I-Biological_structure
- : I-Biological_structure
lung NN I-Biological_structure
field NN I-Biological_structure
. . O

The DT B-Detailed_description
rest NN I-Detailed_description
of IN O
the DT O
examination NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
revealed VBD O
elevated JJ B-Lab_value
levels NNS I-Lab_value
of IN O
C NNP B-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
, , O
lactate JJ B-Diagnostic_procedure
dehydrogenase NN I-Diagnostic_procedure
( ( O
LDH NNP B-Diagnostic_procedure
) ) O
, , O
and CC O
soluble JJ B-Diagnostic_procedure
interleukin JJ I-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
receptor NN I-Diagnostic_procedure
( ( O
sIL JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
2R CD I-Diagnostic_procedure
) ) O
( ( O
Table JJ O
1 CD O
) ) O
. . O

A DT O
chest NN B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
showed VBD O
left JJ B-Detailed_description
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
with IN O
mediastinal JJ B-Detailed_description
shift NN I-Detailed_description
. . O

On IN O
the DT O
first JJ O
hospital NN O
day NN O
, , O
an DT O
intercostal JJ B-Biological_structure
drainage NN B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
was VBD O
inserted VBN O
, , O
and CC O
after IN O
drainage NN O
, , O
chest NN B-Biological_structure
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
( ( O
Fig NNP O
. . O
2 CD O
) ) O
revealed VBD O
an DT O
irregular JJ B-Detailed_description
pleural JJ B-Biological_structure
mass NN B-Sign_symptom
invading VBG O
her PRP$ O
left JJ B-Biological_structure
chest NN I-Biological_structure
wall NN I-Biological_structure
with IN O
rib JJ B-Biological_structure
destruction NN B-Sign_symptom
and CC O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
. . O

The DT O
mass NN B-Sign_symptom
was VBD O
adjacent JJ B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
posterior JJ I-Biological_structure
mediastinum NN I-Biological_structure
, , O
but CC O
the DT O
lateral JJ B-Detailed_description
side NN I-Detailed_description
of IN O
the DT O
mass NN B-Sign_symptom
was VBD O
thick JJ B-Detailed_description
and CC O
invading VBG O
the DT O
chest JJS B-Biological_structure
wall NN I-Biological_structure
, , O
so IN O
we PRP O
diagnosed VBD O
this DT O
mass NN B-Sign_symptom
as IN O
a DT O
chest NN B-Disease_disorder
wall NN I-Disease_disorder
tumor NN I-Disease_disorder
. . O

The DT O
pleural JJ B-Biological_structure
fluid NN I-Biological_structure
was VBD O
serous JJ B-Sign_symptom
and CC O
not RB O
purulent NN B-Sign_symptom
. . O

A DT O
fluid NN B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
showed VBD O
it PRP O
to TO O
be VB O
exudative JJ B-Lab_value
, , O
and CC O
81 CD B-Lab_value
% NN I-Lab_value
of IN I-Lab_value
the DT I-Lab_value
white JJ I-Lab_value
blood NN I-Lab_value
cells NNS I-Lab_value
were VBD I-Lab_value
lymphocytes NNS I-Lab_value
. . O

The DT O
fluid JJ B-Diagnostic_procedure
culture NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
, , O
and CC O
cytology NN B-Diagnostic_procedure
did VBD O
not RB O
show VB O
any DT O
evidence NN O
of IN O
malignancy NN B-Sign_symptom
( ( O
Table JJ O
1 CD O
) ) O
. . O

CT NNP B-Detailed_description
- : I-Detailed_description
guided VBD I-Detailed_description
needle JJ B-Detailed_description
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
. . O

The DT O
histopathology NN B-Diagnostic_procedure
results NNS O
supported VBD O
a DT O
diagnosis NN O
of IN O
diffuse NN B-Disease_disorder
large JJ I-Disease_disorder
B NNP I-Disease_disorder
- : I-Disease_disorder
cell NN I-Disease_disorder
lymphoma NN I-Disease_disorder
( ( O
DLBCL NNP B-Disease_disorder
) ) O
that WDT O
was VBD O
positive JJ B-Lab_value
for IN O
CD10 NNP B-Diagnostic_procedure
and CC O
CD20 NNP B-Diagnostic_procedure
but CC O
negative JJ B-Lab_value
for IN O
CD3 NNP B-Diagnostic_procedure
and CC O
CD5 NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

18 CD B-Diagnostic_procedure
- : I-Diagnostic_procedure
fluorodeoxyglucose JJ I-Diagnostic_procedure
positron NN I-Diagnostic_procedure
emission NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
computed VBD I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
FDG NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PET NNP I-Diagnostic_procedure
/ NNP I-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
) ) O
revealed VBD O
high JJ B-Sign_symptom
FDG NNP I-Sign_symptom
uptake NN I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
chest JJS I-Biological_structure
wall NN I-Biological_structure
mass NN B-Sign_symptom
without IN O
any DT O
other JJ O
uptake NN O
( ( O
Fig NNP O
. . O
4A CD O
and CC O
B NNP O
) ) O
, , O
so IN O
we PRP O
diagnosed VBD O
her PRP O
with IN O
primary JJ B-Disease_disorder
malignant JJ I-Disease_disorder
lymphoma NN I-Disease_disorder
originating VBG B-Biological_structure
from IN I-Biological_structure
the DT I-Biological_structure
chest JJS I-Biological_structure
wall NN I-Biological_structure
. . O

We PRP O
reconfirmed VBD O
her PRP O
medical JJ O
history NN O
, , O
and CC O
she PRP O
never RB O
had VBD O
either CC O
tuberculous JJ O
pleurisy NN O
or CC O
pyothorax NN O
. . O

Her PRP$ O
performance NN B-Diagnostic_procedure
status NN I-Diagnostic_procedure
( ( O
PS NNP B-Diagnostic_procedure
) ) O
was VBD O
3 CD B-Lab_value
because IN O
of IN O
her PRP$ O
back NN B-Biological_structure
pain NN B-Sign_symptom
and CC O
fatigue NN B-Sign_symptom
. . O

Owing VBG O
to TO O
her PRP$ O
bad JJ O
PS NNP O
and CC O
age NN O
, , O
it PRP O
was VBD O
difficult JJ O
to TO O
perform VB O
an DT O
operation NN O
or CC O
administer NN O
combination NN O
chemotherapy NN O
with IN O
Rituximab NNP B-Medication
, , O
so RB O
low JJ B-Detailed_description
- : I-Detailed_description
dose JJ I-Detailed_description
oral JJ O
etoposide NN B-Medication
( ( O
50 CD B-Dosage
mg NNS I-Dosage
/ JJ I-Dosage
day NN I-Dosage
d1 VBD I-Dosage
- : I-Dosage
14 CD I-Dosage
, , I-Dosage
q28 NN I-Dosage
) ) O
was VBD O
administered VBN O
. . O

Her PRP$ O
pleural JJ B-Sign_symptom
effusion NN I-Sign_symptom
disappeared VBD O
within IN O
two CD O
weeks NNS O
, , O
her PRP$ O
back RB B-Biological_structure
pain NN B-Sign_symptom
disappeared VBD O
, , O
and CC O
her PRP$ O
PS NNP B-Diagnostic_procedure
improved VBD O
to TO O
1 CD B-Lab_value
within IN O
a DT O
month NN O
. . O

Chest NNP B-Diagnostic_procedure
CT NNP I-Diagnostic_procedure
performed VBD O
four CD O
months NNS O
later RB O
showed VBD O
complete JJ B-Lab_value
response NN I-Lab_value
( ( O
Fig NNP O
. . O
4C CD O
and CC O
D NNP O
) ) O
. . O

She PRP O
continued VBD O
oral JJ O
chemotherapy NN B-Medication
and CC O
maintained VBD O
a DT O
good JJ B-Lab_value
PS NNP B-Diagnostic_procedure
for IN O
one CD O
year NN O
after IN O
the DT O
diagnosis NN O
. . O

-DOCSTART- NN -X-

A DT O
73 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
initially RB O
referred JJ O
19 CD O
months NNS O
prior RB O
to TO O
the DT O
current JJ O
presentation NN O
, , O
at IN O
which WDT O
time NN O
fluorescein NN B-Detailed_description
and CC O
indocyanine NN B-Detailed_description
green JJ I-Detailed_description
angiography NN B-Diagnostic_procedure
showed VBD O
a DT O
medium NN B-Detailed_description
- : I-Detailed_description
sized VBN I-Detailed_description
subfoveal JJ B-Detailed_description
classic JJ B-Detailed_description
CNV NNP B-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
, , O
which WDT O
had VBD O
not RB B-Detailed_description
been VBN I-Detailed_description
previously RB I-Detailed_description
treated VBN I-Detailed_description
. . O

She PRP O
did VBD O
not RB O
return VB O
for IN O
treatment NN B-Therapeutic_procedure
until IN O
the DT O
current JJ O
presentation NN O
, , O
when WRB O
she PRP O
noted VBD O
decreased JJ B-Sign_symptom
vision NN I-Sign_symptom
in IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
. . O

The DT O
best JJS B-Diagnostic_procedure
- : I-Diagnostic_procedure
corrected VBN I-Diagnostic_procedure
visual JJ I-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
( ( O
BCVA NNP B-Diagnostic_procedure
) ) O
was VBD O
20 CD B-Lab_value
/ JJ I-Lab_value
100 CD I-Lab_value
. . O

Slit NNP B-Diagnostic_procedure
lamp NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
small JJ B-Detailed_description
yellowish JJ B-Color
patch NN B-Sign_symptom
in IN O
the DT O
perifoveal JJ B-Biological_structure
region NN I-Biological_structure
and CC O
retinal JJ B-Sign_symptom
edema NN I-Sign_symptom
. . O

Structural JJ B-Detailed_description
OCT NNP B-Diagnostic_procedure
revealed VBD O
the DT O
retinal JJ B-Sign_symptom
elevation NN I-Sign_symptom
, , O
subretinal JJ B-Sign_symptom
fluid NN I-Sign_symptom
and CC O
a DT O
hyper JJ B-Biological_structure
- : I-Biological_structure
reflective NN I-Biological_structure
elongated VBD B-Sign_symptom
area NN I-Sign_symptom
above IN B-Biological_structure
RPE NNP I-Biological_structure
indicating VBG O
type NN B-Lab_value
II NNP I-Lab_value
CNV NNP B-Disease_disorder
. . O

Anti NNP B-Therapeutic_procedure
- : I-Therapeutic_procedure
angiogenic JJ I-Therapeutic_procedure
treatment NN I-Therapeutic_procedure
with IN O
intravitreal JJ O
aflibercept JJ B-Medication
injections NNS O
were VBD O
administered VBN O
with IN O
a DT O
treat NN B-Detailed_description
- : I-Detailed_description
and CC I-Detailed_description
- : I-Detailed_description
extend NN I-Detailed_description
regimen NNS I-Detailed_description
. . O

OCT NNP B-Diagnostic_procedure
angiograms NNS B-Detailed_description
( ( O
Fig NNP O
. . O
1 CD O
) ) O
showed VBD O
noticeable JJ B-Lab_value
reduction NN I-Lab_value
in IN O
CNV NNP B-Diagnostic_procedure
flow JJ I-Diagnostic_procedure
area NN I-Diagnostic_procedure
by IN O
1 CD O
- : O
2 CD O
days NNS O
post NN O
injection NN O
, , O
with IN O
continued JJ B-Lab_value
reduction NN I-Lab_value
at IN O
1 CD O
week NN O
and CC O
2 CD O
weeks NNS O
. . O

CNV NNP B-Diagnostic_procedure
flow JJ I-Diagnostic_procedure
area NN I-Diagnostic_procedure
and CC O
vessel NN B-Diagnostic_procedure
density NN I-Diagnostic_procedure
were VBD O
reduced VBN B-Lab_value
, , O
probably RB O
due JJ O
to TO O
the DT O
decreased VBN O
flow NN O
or CC O
temporary JJ O
closure NN O
of IN O
the DT O
smaller JJR O
anastomoses NNS O
. . O

Significant NNP B-Severity
re VBZ B-Lab_value
- : I-Lab_value
appearance NN I-Lab_value
of IN O
CNV NNP B-Disease_disorder
was VBD O
noticeable JJ O
at IN O
4 CD O
weeks NNS O
after IN O
the DT O
first JJ O
injection NN O
and CC O
again RB O
at IN O
6 CD O
weeks NNS O
after IN O
the DT O
second JJ O
injection NN O
. . O

The DT O
vascular JJ O
pattern NN O
of IN O
the DT O
re NN B-Detailed_description
- : I-Detailed_description
enlarged VBN I-Detailed_description
CNV NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
1A CD O
) ) O
was VBD O
very RB O
similar JJ O
to TO O
the DT O
initial JJ O
pretreatment NN O
CNV NNP O
, , O
suggesting VBG O
that IN O
the DT O
recurrence NN O
may MD O
be VB O
reopening VBG O
of IN O
original JJ O
channels NNS O
rather RB O
than IN O
growth NN O
of IN O
new JJ O
vessels NNS O
. . O

Comparing VBG O
the DT O
CNV NNP O
network NN O
prior RB O
to TO O
the DT O
3rd CD O
injection NN O
to TO O
the DT O
baseline NN O
, , O
it PRP O
is VBZ O
notable JJ O
that IN O
there EX O
were VBD O
fewer JJR O
smaller JJR O
channels NNS O
, , O
while IN O
the DT O
larger JJR O
caliber NN O
channels NNS O
remained VBN O
. . O

Quantitative JJ O
measurements NNS O
from IN O
OCT NNP B-Diagnostic_procedure
angiography NN B-Detailed_description
( ( O
Fig NNP O
. . O
2A CD O
) ) O
showed VBD O
reduction NN B-Lab_value
in IN O
CNV NNP B-Diagnostic_procedure
flow JJ I-Diagnostic_procedure
area NN I-Diagnostic_procedure
and CC O
flow JJ B-Diagnostic_procedure
index NN I-Diagnostic_procedure
over IN B-Duration
the DT I-Duration
first JJ I-Duration
2 CD I-Duration
weeks NNS I-Duration
with IN O
subsequent JJ O
return NN O
. . O

Retinal JJ B-Sign_symptom
thickness NN I-Sign_symptom
( ( O
Fig NNP O
. . O
2B CD O
) ) O
showed VBD O
the DT O
fluid NN O
resorption NN O
over IN B-Duration
the DT I-Duration
first JJ I-Duration
4 CD I-Duration
weeks NNS I-Duration
in IN O
the DT O
first JJ O
treatment NN O
cycle NN O
continuing VBG O
at IN O
least JJS O
2 CD O
weeks NNS O
into IN O
the DT O
second JJ O
treatment NN O
cycle NN O
, , O
at IN O
which WDT O
time NN O
no DT O
fluid NN O
remained VBD O
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

But CC O
fluid NN B-Sign_symptom
re VBP I-Sign_symptom
- : I-Sign_symptom
accumulated VBN I-Sign_symptom
under IN B-Biological_structure
the DT I-Biological_structure
retina NN I-Biological_structure
6 CD O
weeks NNS O
after IN O
the DT O
2nd CD O
injection NN O
. . O

Visual JJ B-Diagnostic_procedure
acuity NN I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
2B CD O
) ) O
continued VBD B-Lab_value
to TO I-Lab_value
improve VB I-Lab_value
over IN O
the DT O
3 CD O
treatment NN O
cycles NNS O
. . O

-DOCSTART- NN -X-

A DT O
73 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
who WP O
had VBD O
been VBN O
transferred VBN O
to TO O
our PRP$ O
emergency NN B-Nonbiological_location
room NN I-Nonbiological_location
due JJ O
to TO O
sudden JJ B-Detailed_description
chest NN B-Biological_structure
pain NN B-Sign_symptom
was VBD O
diagnosed VBN O
with IN O
ST NNP B-Disease_disorder
- : I-Disease_disorder
segment NN I-Disease_disorder
elevation NN I-Disease_disorder
myocardial JJ I-Disease_disorder
infarction NN I-Disease_disorder
( ( O
STEMI NNP B-Disease_disorder
) ) O
. . O

He PRP O
had VBD O
no DT O
coronary JJ O
risk NN O
factors NNS O
except IN O
for IN O
a DT O
history NN O
of IN O
smoking VBG O
for IN O
50 CD O
years NNS O
. . O

Primary NNP B-Detailed_description
percutaneous JJ B-Biological_structure
coronary JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
was VBD O
performed VBN O
, , O
and CC O
a DT O
long JJ B-Detailed_description
, , O
string VBG B-Shape
- : I-Shape
shaped VBN I-Shape
contrast NN B-Sign_symptom
defect NN I-Sign_symptom
was VBD O
observed VBN O
in IN O
the DT O
left NN B-Biological_structure
anterior JJ I-Biological_structure
descending VBG I-Biological_structure
artery NN I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

Optical JJ B-Diagnostic_procedure
coherence NN I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
OCT NNP B-Diagnostic_procedure
) ) O
imaging VBG O
revealed VBD O
an DT O
odd JJ B-Detailed_description
, , O
smooth JJ B-Texture
- : I-Texture
surfaced VBD I-Texture
50 CD B-Distance
- : I-Distance
mm NN I-Distance
long JJ I-Distance
object NN B-Sign_symptom
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

A DT O
long JJ B-Detailed_description
, , O
white JJ B-Color
object NN B-Sign_symptom
which WDT O
looked VBD B-Detailed_description
like IN I-Detailed_description
a DT I-Detailed_description
parasitic JJ I-Detailed_description
worm NN I-Detailed_description
was VBD O
retrieved VBN O
via IN O
intracoronary JJ B-Therapeutic_procedure
aspiration NN I-Therapeutic_procedure
and CC O
revascularization NN B-Therapeutic_procedure
was VBD O
successfully RB B-Lab_value
completed VBN I-Lab_value
since IN O
neither DT O
plaque JJ B-Sign_symptom
rupture NN I-Sign_symptom
or CC O
the DT O
presence NN O
of IN O
thrombus NN B-Sign_symptom
was VBD O
detected VBN O
by IN O
OCT NNP O
( ( O
Fig NNP O
. . O
1C CD O
) ) O
. . O

On IN O
the DT O
eleventh JJ O
hospital NN O
day NN O
, , O
transthoracic NN B-Biological_structure
echocardiography NN B-Diagnostic_procedure
revealed VBD O
a DT O
new JJ O
floating VBG B-Detailed_description
object NN B-Sign_symptom
in IN O
the DT O
left JJ B-Biological_structure
atrium NN I-Biological_structure
. . O

Contrast NNP B-Diagnostic_procedure
computed VBD I-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
revealed VBD O
a DT O
huge JJ B-Detailed_description
7 CD B-Area
× $ I-Area
6 CD I-Area
cm JJ I-Area
mass NN B-Sign_symptom
that WDT O
was VBD O
recognized VBN O
at IN O
admission NN O
in IN O
the DT O
right JJ B-Biological_structure
upper JJ I-Biological_structure
pulmonary JJ I-Biological_structure
lobe NN I-Biological_structure
with IN O
direct JJ B-Detailed_description
pulmonary JJ I-Detailed_description
vein NN I-Detailed_description
invasion NN I-Detailed_description
( ( O
Fig NNP O
. . O
1D CD O
) ) O
. . O

Although IN O
the DT O
bronchoscopic NN B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
were VBD O
negative JJ O
for IN O
a DT O
lung NN B-Sign_symptom
tumor NN I-Sign_symptom
, , O
a DT O
histopathologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
aspirated JJ B-Detailed_description
coronary JJ B-Biological_structure
object NN O
revealed VBD O
pleomorphic JJ B-Detailed_description
lung NN B-Biological_structure
carcinoma NN B-Disease_disorder
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
STEMI NNP B-Disease_disorder
due JJ O
to TO O
coronary JJ B-Biological_structure
embolization NN B-Sign_symptom
associated VBN O
with IN O
lung NN B-Biological_structure
carcinoma NN B-Disease_disorder
. . O

Brain NNP B-Biological_structure
MRI NNP B-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
patient NN O
had VBD O
an DT O
asymptomatic JJ B-Detailed_description
cerebral JJ B-Biological_structure
infarction NN B-Sign_symptom
in IN O
the DT O
right JJ B-Biological_structure
frontal NN I-Biological_structure
lobe NN I-Biological_structure
and CC O
a DT O
small JJ B-Detailed_description
parietal JJ B-Biological_structure
lobe NN I-Biological_structure
lesion NN B-Sign_symptom
was VBD O
diagnosed VBN O
to TO O
be VB O
metastasis NN B-Sign_symptom
. . O

Given VBN O
all PDT O
these DT O
observations NNS O
, , O
he PRP O
was VBD O
diagnosed VBN O
with IN O
right JJ B-Biological_structure
lung NN I-Biological_structure
carcinoma NN B-Disease_disorder
, , O
stage NN B-Detailed_description
IV NNP I-Detailed_description
( ( O
c SYM B-Detailed_description
- : I-Detailed_description
T2bN2M1b NN I-Detailed_description
) ) O
. . O

He PRP O
was VBD O
treated VBN O
according VBG O
to TO O
the DT O
chemotherapy NN B-Medication
regimens VBZ O
( ( O
carboplatin NN B-Medication
& CC O
paclitaxel NN B-Medication
) ) O
known VBN O
to TO O
be VB O
effective JJ O
for IN O
the DT O
treatment NN O
of IN O
advanced JJ O
non JJ O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

He PRP O
responded VBD O
to TO O
the DT O
treatment NN O
and CC O
showed VBD O
a DT O
good JJ B-Lab_value
clinical JJ B-Diagnostic_procedure
course NN I-Diagnostic_procedure
afterwards NNS O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Chemotherapy NN B-Medication
with IN O
a DT O
total NN O
of IN O
9 CD B-Dosage
cycles NNS I-Dosage
of IN O
the DT O
same JJ O
regimen NN O
was VBD O
used VBN O
and CC O
the DT O
carcinoma NN B-Diagnostic_procedure
progression NN I-Diagnostic_procedure
was VBD O
suppressed VBN B-Lab_value
. . O

He PRP O
has VBZ O
been VBN O
doing VBG B-Sign_symptom
well RB I-Sign_symptom
for IN O
more JJR B-Duration
than IN I-Duration
two CD I-Duration
years NNS I-Duration
of IN O
PCI NNP B-Therapeutic_procedure
and CC O
has VBZ O
been VBN O
followed VBN O
- : O
up RB O
regularly RB B-Detailed_description
. . O

-DOCSTART- NN -X-

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
68 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
female NN O
with IN O
no DT O
past JJ O
medical JJ O
history NN O
, , O
presented VBN O
with IN O
an DT O
upper JJ B-Biological_structure
gastrointestinal NN I-Biological_structure
bleeding NN B-Sign_symptom
and CC O
pain NN B-Sign_symptom
in IN O
left JJ B-Biological_structure
upper JJ I-Biological_structure
abdomen NNS I-Biological_structure
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
found VBD O
a DT O
splenomegaly NN B-Sign_symptom
and CC O
signs NNS O
of IN O
portosystemic JJ B-Disease_disorder
collateral JJ I-Disease_disorder
formation NN I-Disease_disorder
including VBG O
abdominal JJ B-Biological_structure
wall NN I-Biological_structure
dilated VBD B-Sign_symptom
veins NNS I-Sign_symptom
and CC O
rectal JJ B-Biological_structure
haemorrhoids NNS B-Sign_symptom
. . O

No DT O
biological JJ B-Sign_symptom
abnormalities NNS I-Sign_symptom
were VBD O
noted VBN O
besides IN O
those DT O
due JJ O
to TO O
hypersplenism NN B-Disease_disorder
( ( O
anaemia NN B-Sign_symptom
and CC O
thrombocytopenia NN B-Sign_symptom
) ) O
. . O

The DT O
patient JJ O
underwent JJ O
upper JJ B-Biological_structure
gastrointestinal NN I-Biological_structure
endoscopy NN B-Diagnostic_procedure
that WDT O
showed VBD O
stage NN B-Detailed_description
III NNP I-Detailed_description
oesophageal NN B-Biological_structure
varices NNS B-Sign_symptom
with IN O
portal JJ B-Disease_disorder
hypertensive JJ I-Disease_disorder
gastropathy NN I-Disease_disorder
and CC O
red JJ B-Sign_symptom
signs NNS I-Sign_symptom
. . O

Ultrasonography NNP B-Diagnostic_procedure
revealed VBD O
a DT O
fusiform JJ B-Sign_symptom
dilatation NN I-Sign_symptom
of IN O
the DT O
portal JJ B-Biological_structure
bifurcation NN I-Biological_structure
measuring VBG O
40 CD B-Distance
mm NN I-Distance
in IN O
diameter NN O
with IN O
dilated JJ B-Detailed_description
branches NNS I-Detailed_description
; : O
no DT O
signs NNS B-Sign_symptom
of IN I-Sign_symptom
portal JJ I-Sign_symptom
thrombosis NN I-Sign_symptom
were VBD O
detected VBN O
( ( O
Figure NNP O
1 CD O
) ) O
. . O

The DT O
portal JJ B-Biological_structure
Doppler NNP B-Diagnostic_procedure
study NN I-Diagnostic_procedure
showed VBD O
a DT O
normal JJ B-Lab_value
hepatopetal JJ I-Lab_value
flow NN I-Lab_value
. . O

Other JJ B-Sign_symptom
signs NNS I-Sign_symptom
of IN I-Sign_symptom
portal JJ I-Sign_symptom
hypertension NN I-Sign_symptom
were VBD O
found VBN O
, , O
including VBG O
splenomegaly NN B-Sign_symptom
, , O
repermeation NN B-Sign_symptom
of IN O
the DT O
umbilical JJ B-Biological_structure
vein NN I-Biological_structure
and CC O
a DT O
splenorenal JJ B-Biological_structure
collateral NN B-Sign_symptom
circulation NN I-Sign_symptom
. . O

A DT O
complementary JJ O
angio NN B-Biological_structure
- : O
CT NN B-Diagnostic_procedure
allowed VBD O
a DT O
better RBR O
assessment NN O
of IN O
the DT O
portal JJ O
system NN O
that WDT O
contained VBD O
some DT O
thin JJ B-Sign_symptom
calcifications NNS I-Sign_symptom
in IN O
the DT O
aneurysmal JJ B-Biological_structure
wall NN I-Biological_structure
and CC O
the DT O
main JJ B-Biological_structure
portal JJ I-Biological_structure
trunk NN I-Biological_structure
( ( O
Figure NNP O
2 CD O
, , O
Figure NNP O
3 CD O
, , O
Figure NNP O
4 CD O
) ) O
. . O

Other JJ B-Sign_symptom
signs NNS I-Sign_symptom
of IN I-Sign_symptom
portal JJ I-Sign_symptom
hypertension NN I-Sign_symptom
were VBD O
noted VBN O
such JJ O
as IN O
oesophageal NN B-Biological_structure
and CC O
gastric JJ B-Biological_structure
varices NNS B-Sign_symptom
, , O
parietal JJ B-Biological_structure
collateral NN B-Sign_symptom
circulation NN I-Sign_symptom
associated VBN O
to TO O
ultrasonography JJ O
findings NNS O
. . O

Liver NNP B-Disease_disorder
cirrhosis NN I-Disease_disorder
was VBD O
confirmed VBN O
by IN O
transcient NN B-Diagnostic_procedure
elastometry NN I-Diagnostic_procedure
and CC O
biopsy NN B-Diagnostic_procedure
. . O

-DOCSTART- NN -X-

This DT O
young JJ B-Age
boy NN O
is VBZ O
the DT O
first JJ O
child NN O
of IN O
healthy JJ B-Detailed_description
non FW B-Detailed_description
- : I-Detailed_description
consanguineous JJ I-Detailed_description
, , O
white JJ O
British JJ O
parents NNS O
. . O

He PRP O
was VBD O
born VBN O
at IN B-Detailed_description
term NN I-Detailed_description
following VBG O
an DT O
uneventful JJ B-Detailed_description
pregnancy NN I-Detailed_description
weighing VBG O
3132 CD B-Weight
g NN I-Weight
( ( O
9th CD O
- : O
25th CD O
centile NN O
) ) O
. . O

Early RB B-Diagnostic_procedure
development NN I-Diagnostic_procedure
was VBD O
thought VBN O
to TO O
be VB O
normal JJ B-Lab_value
. . O

At IN O
approximately RB O
6 CD O
months NNS O
of IN O
age NN O
he PRP O
developed VBD O
tonic JJ B-Detailed_description
upward RB I-Detailed_description
eye NN B-Sign_symptom
deviation NN I-Sign_symptom
associated VBN O
with IN O
flexion NN B-Sign_symptom
of IN O
his PRP$ O
arms NNS B-Biological_structure
and CC O
neck NN B-Biological_structure
consistent NN O
with IN O
infantile JJ B-Disease_disorder
spasms NNS I-Disease_disorder
. . O

An DT O
electroencephalograph NN B-Diagnostic_procedure
( ( O
EEG NNP B-Diagnostic_procedure
) ) O
at IN O
this DT O
time NN O
was VBD O
grossly RB B-Lab_value
abnormal JJ I-Lab_value
( ( O
hypsarrhythmia NN B-Sign_symptom
) ) O
and CC O
strongly RB O
supported VBD O
a DT O
diagnosis NN O
of IN O
West NNP B-Disease_disorder
Syndrome NNP I-Disease_disorder
. . O

Cranial JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
was VBD O
reported VBN O
as IN O
normal JJ B-Lab_value
. . O

Prednisolone NN B-Medication
was VBD O
prescribed VBN O
and CC O
treated VBN O
the DT O
seizures NNS B-Sign_symptom
effectively RB O
. . O

Steroids NNS B-Medication
were VBD O
weaned VBN O
over IN B-Duration
6 CD I-Duration
weeks NNS I-Duration
and CC O
he PRP O
remained VBD O
seizure JJ B-Sign_symptom
free JJ O
for IN O
a DT O
further JJ B-Duration
6 CD I-Duration
months NNS I-Duration
. . O

By IN O
the DT O
age NN O
of IN O
1 CD O
year NN O
, , O
it PRP O
was VBD O
apparent JJ O
that IN O
his PRP$ O
early JJ O
developmental JJ B-Diagnostic_procedure
progress NN I-Diagnostic_procedure
was VBD O
not RB B-Lab_value
being VBG I-Lab_value
maintained VBN I-Lab_value
and CC O
that IN O
he PRP O
was VBD O
functioning VBG O
at IN O
the DT O
6 CD B-Lab_value
- : I-Lab_value
8 CD I-Lab_value
month NN I-Lab_value
developmental JJ B-Diagnostic_procedure
stage NN I-Diagnostic_procedure
. . O

Seizures NNS B-Sign_symptom
returned VBD O
shortly RB O
after IN O
his PRP$ O
first JJ O
birthday NN O
and CC O
were VBD O
prolonged VBN B-Detailed_description
, , O
frequent JJ B-Detailed_description
and CC O
on IN B-Detailed_description
occasion NN I-Detailed_description
focal JJ I-Detailed_description
, , O
involving VBG O
his PRP$ O
right NN B-Biological_structure
arm NN I-Biological_structure
, , O
leg NN B-Biological_structure
and CC O
right JJ B-Biological_structure
side NN I-Biological_structure
of IN I-Biological_structure
face NN I-Biological_structure
. . O

Clonazepam NNP B-Medication
briefly NN O
improved VBD O
seizure NN B-Sign_symptom
frequency NN O
, , O
but CC O
subsequently RB O
his PRP$ O
epilepsy NN B-Disease_disorder
has VBZ O
proved VBN O
refractory NN B-Detailed_description
to TO I-Detailed_description
various JJ I-Detailed_description
combinations NNS I-Detailed_description
of IN I-Detailed_description
anticonvulsant JJ I-Detailed_description
therapy NN I-Detailed_description
. . O

Prolonged JJ B-Detailed_description
seizures NNS B-Sign_symptom
of IN O
more JJR B-Detailed_description
than IN I-Detailed_description
60 CD I-Detailed_description
min NNS I-Detailed_description
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
stepwise NN B-Lab_value
regression NN I-Lab_value
in IN O
his PRP$ O
neurodevelopment NN B-Diagnostic_procedure
. . O

Seizure NN B-Sign_symptom
semiology NN O
is VBZ O
now RB O
predominantly RB O
one CD O
of IN O
epilepsia NN B-Disease_disorder
partialis NN I-Disease_disorder
continua NN I-Disease_disorder
involving VBG O
the DT O
right JJ B-Biological_structure
side NN I-Biological_structure
of IN I-Biological_structure
his PRP$ I-Biological_structure
face NN I-Biological_structure
, , O
right JJ B-Biological_structure
arm NN I-Biological_structure
and CC O
right JJ B-Biological_structure
leg NN I-Biological_structure
. . O

The DT O
development NN O
of IN O
focal JJ B-Detailed_description
seizures NNS B-Sign_symptom
and CC O
the DT O
progressive JJ B-Detailed_description
nature NN O
of IN O
the DT O
condition NN O
prompted VBD O
a DT O
second JJ O
cranial JJ B-Biological_structure
MRI NNP B-Diagnostic_procedure
at IN O
the DT O
age NN O
of IN O
2 CD O
years NNS O
6 CD O
months NNS O
. . O

By IN O
contrast NN O
with IN O
the DT O
previous JJ O
scan JJ O
, , O
this DT O
MRI NNP B-Diagnostic_procedure
revealed VBD O
symmetrical JJ B-Detailed_description
subcortical JJ B-Biological_structure
white JJ I-Biological_structure
matter NN I-Biological_structure
lesions NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1A CD O
) ) O
with IN O
thinning NN B-Sign_symptom
of IN O
the DT O
anterior JJ B-Biological_structure
and CC I-Biological_structure
genu NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
corpus NN I-Biological_structure
callosum NN I-Biological_structure
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

On IN O
examination NN B-Diagnostic_procedure
, , O
the DT O
patient NN O
had VBD O
small JJ B-Detailed_description
, , O
round NN B-Shape
, , O
anteriorly RB B-Detailed_description
rotated VBN I-Detailed_description
ears NNS B-Biological_structure
and CC O
a DT O
broad JJ B-Detailed_description
nasal NN B-Biological_structure
root NN I-Biological_structure
. . O

He PRP O
demonstrated VBD O
no DT B-Lab_value
visual JJ B-Diagnostic_procedure
awareness NN I-Diagnostic_procedure
but CC O
startled VBD B-Sign_symptom
to TO I-Sign_symptom
loud VB I-Sign_symptom
noise NN I-Sign_symptom
. . O

Tone NN B-Diagnostic_procedure
was VBD O
increased VBN B-Lab_value
in IN O
all DT B-Biological_structure
4 CD I-Biological_structure
limbs NNS I-Biological_structure
with IN O
internal JJ B-Sign_symptom
rotation NN I-Sign_symptom
of IN O
both DT B-Biological_structure
legs NNS I-Biological_structure
at IN I-Biological_structure
the DT I-Biological_structure
hips NNS I-Biological_structure
. . O

Reflexes NNS B-Diagnostic_procedure
were VBD O
pathologically RB B-Lab_value
brisk JJ I-Lab_value
. . O

Brief NNP B-Detailed_description
myoclonic JJ B-Sign_symptom
jerks NNS I-Sign_symptom
were VBD O
evident JJ O
throughout IN O
the DT O
examination NN O
. . O

-DOCSTART- NN -X-

A DT O
33 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
Moroccan JJ O
man NN O
with IN O
a DT O
5 CD B-Duration
- : I-Duration
month NN I-Duration
history NN O
of IN O
recurring VBG B-Detailed_description
sinusitis NN B-Disease_disorder
presented VBN O
with IN O
temperature NN B-Sign_symptom
, , O
myalgia NN B-Sign_symptom
, , O
cough NN B-Sign_symptom
, , O
and CC O
hemoptysis NN B-Sign_symptom
. . O

Thoracic NNP B-Biological_structure
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
reduced JJ B-Lab_value
vesicular JJ B-Diagnostic_procedure
murmur NN I-Diagnostic_procedure
, , O
and CC O
chest JJS B-Biological_structure
X SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
ray NN I-Diagnostic_procedure
showed VBD O
bilateral JJ B-Detailed_description
diffuse NN B-Detailed_description
alveolar JJ B-Biological_structure
infiltrates NNS B-Sign_symptom
. . O

Laboratory NN B-Diagnostic_procedure
analyses NNS I-Diagnostic_procedure
showed VBD O
elevation NN B-Lab_value
of IN O
acute JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
phase NN I-Diagnostic_procedure
proteins NNS I-Diagnostic_procedure
( ( O
CRP NNP B-Diagnostic_procedure
26 CD B-Lab_value
mg NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
and CC O
creatinine NN B-Diagnostic_procedure
( ( O
1 CD B-Lab_value
. . I-Lab_value
2 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
with IN O
nonnephrotic JJ B-Detailed_description
proteinuria NNS B-Sign_symptom
and CC O
microscopic NN B-Detailed_description
glomerular JJ B-Detailed_description
hematuria NN B-Sign_symptom
. . O

An DT O
antibiotic JJ B-Medication
therapy NN I-Medication
for IN O
community NN B-Detailed_description
acquired VBN I-Detailed_description
and CC O
atypical JJ B-Detailed_description
pneumoniae NN B-Disease_disorder
with IN O
levofloxacin JJ B-Medication
500 CD B-Dosage
mg JJ I-Dosage
daily JJ I-Dosage
iv NN O
was VBD O
established VBN O
, , O
but CC O
on IN O
the DT O
3rd CD O
day NN O
from IN O
admission NN O
the DT O
patient NN O
developed VBD O
respiratory JJ B-Disease_disorder
failure NN I-Disease_disorder
unresponsive JJ O
to TO O
noninvasive JJ B-Detailed_description
ventilation NN B-Therapeutic_procedure
and CC O
had VBD O
to TO O
be VB O
intubated VBN B-Therapeutic_procedure
. . O

White NNP B-Color
lung NN B-Biological_structure
with IN O
consolidations NNS B-Sign_symptom
and CC O
ground NN B-Sign_symptom
glass NN I-Sign_symptom
areas NNS I-Sign_symptom
at IN O
computed JJ B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
scan JJ O
( ( O
Fig NNP O
. . O
1 CD O
) ) O
, , O
diffuse VBP B-Detailed_description
airways VBZ B-Biological_structure
bleeding NN B-Sign_symptom
at IN O
fiberoptic JJ B-Detailed_description
bronchoscopy NN B-Diagnostic_procedure
, , O
mild JJ B-Severity
normocytic JJ B-Detailed_description
anemia NN B-Diagnostic_procedure
( ( O
9 CD B-Lab_value
g NN I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
) ) O
, , O
and CC O
ANCA NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PR3 NNP I-Diagnostic_procedure
positivity NN B-Lab_value
( ( O
18 CD B-Lab_value
. . I-Lab_value
9 CD I-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
were VBD O
consistent JJ O
with IN O
the DT O
diagnosis NN O
of IN O
GPA NNP B-Disease_disorder
. . O

Despite IN O
maximal JJ B-Detailed_description
ventilatory JJ B-Therapeutic_procedure
support NN I-Therapeutic_procedure
, , O
gas NN B-Diagnostic_procedure
exchange NN I-Diagnostic_procedure
did VBD B-Lab_value
not RB I-Lab_value
improve VB I-Lab_value
( ( O
pH JJ B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
33 CD I-Lab_value
, , O
PaO2 NNP B-Diagnostic_procedure
71 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
PaCO2 NNP B-Diagnostic_procedure
51 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
HCO3 NNP B-Diagnostic_procedure
- : O
25 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
SaO2 NNP B-Diagnostic_procedure
94 CD B-Lab_value
% NN I-Lab_value
) ) O
requiring VBG O
extracorporeal JJ B-Therapeutic_procedure
membrane NN I-Therapeutic_procedure
oxygenation NN I-Therapeutic_procedure
( ( O
ECMO NNP B-Therapeutic_procedure
) ) O
. . O

Treatment NN O
with IN O
high JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
methylprednisolone NN B-Medication
( ( O
1 CD B-Dosage
g NNS I-Dosage
daily RB I-Dosage
for IN O
3 CD B-Duration
days NNS I-Duration
and CC O
1 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
kg VBD I-Dosage
daily RB I-Dosage
thereafter RB O
) ) O
, , O
cyclophosphamide NN B-Medication
( ( O
1 CD B-Dosage
. . I-Dosage
2 CD I-Dosage
g JJ I-Dosage
/ NN I-Dosage
pulse NN I-Dosage
every DT I-Dosage
2 CD I-Dosage
weeks NNS I-Dosage
for IN I-Dosage
the DT I-Dosage
1st CD I-Dosage
3 CD I-Dosage
pulses NNS I-Dosage
, , O
followed VBN O
by IN O
infusions NNS O
every DT B-Dosage
3 CD I-Dosage
weeks NNS I-Dosage
for IN I-Dosage
the DT I-Dosage
next JJ I-Dosage
2 CD I-Dosage
pulses NNS I-Dosage
) ) O
, , O
and CC O
plasma JJ B-Therapeutic_procedure
exchange NN I-Therapeutic_procedure
( ( O
PE NNP B-Therapeutic_procedure
) ) O
, , O
according VBG O
to TO O
European NNP B-Detailed_description
vasculitis NN I-Detailed_description
study NN I-Detailed_description
group NN I-Detailed_description
recommendations NNS I-Detailed_description
, , O
[ VBP O
4 CD O
] NN O
was VBD O
immediately RB O
started VBN O
with IN O
respiratory NN B-Diagnostic_procedure
improvement NN B-Lab_value
that WDT O
allowed VBD O
ECMO NNP B-Therapeutic_procedure
and CC O
orotracheal JJ B-Therapeutic_procedure
tube NN I-Therapeutic_procedure
withdrawal NN O
and CC O
subsequent JJ O
discharge NN O
from IN O
intensive JJ B-Nonbiological_location
care NN I-Nonbiological_location
unit NN I-Nonbiological_location
. . O

After IN O
9 CD O
days NNS O
from IN O
the DT O
beginning NN O
of IN O
treatment NN O
ANCA NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
PR3 NN I-Diagnostic_procedure
levels NNS O
normalized VBN B-Lab_value
( ( O
3 CD B-Lab_value
U NNP I-Lab_value
/ NNP I-Lab_value
mL NN I-Lab_value
) ) O
. . O

Two CD O
months NNS O
later RB O
, , O
after IN O
the DT O
5th JJ B-Detailed_description
bolus NN I-Detailed_description
of IN O
cyclophosphamide NN B-Medication
and CC O
with IN O
prednisone NN B-Medication
0 CD B-Dosage
. . I-Dosage
3 CD I-Dosage
mg JJ I-Dosage
/ NNP I-Dosage
kg NN I-Dosage
/ NNP I-Dosage
day NN I-Dosage
, , O
the DT O
patient NN O
complained VBD O
arthromyalgia NNS B-Sign_symptom
and CC O
testicular JJ B-Biological_structure
pain NN B-Sign_symptom
with IN O
edema NN B-Sign_symptom
, , O
cough NN B-Sign_symptom
, , O
and CC O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
: : O
laboratory NN B-Diagnostic_procedure
data NNS I-Diagnostic_procedure
showed VBD O
worsening NN B-Lab_value
of IN O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
, , O
mild JJ B-Severity
anemia NN B-Sign_symptom
, , O
and CC O
hypoxemia NN B-Sign_symptom
( ( O
PaO2 NNP B-Diagnostic_procedure
61 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
) ) O
. . O

Epididymitis NN B-Disease_disorder
was VBD O
confirmed VBN O
by IN O
ultrasound NN B-Diagnostic_procedure
. . O

Because IN O
of IN O
rapidly RB B-Detailed_description
progressive JJ I-Detailed_description
renal JJ B-Disease_disorder
failure NN I-Disease_disorder
( ( O
estimated VBN O
glomerular JJ B-Diagnostic_procedure
filtration NN I-Diagnostic_procedure
rate NN I-Diagnostic_procedure
35 CD B-Lab_value
mL NN I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
) ) O
renal NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
and CC O
showed VBN O
prominent JJ B-Severity
intracapillary JJ B-Biological_structure
and CC O
extracapillary JJ B-Biological_structure
proliferation NN B-Sign_symptom
, , O
with IN O
the DT O
formation NN O
of IN O
some DT O
fibrocellular JJ B-Sign_symptom
crescents NNS I-Sign_symptom
and CC O
focal JJ B-Detailed_description
capillary JJ B-Biological_structure
necrosis NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

Lung NNP B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
- : O
scan JJ O
and CC O
fiberoptic JJ B-Detailed_description
bronchoscopy NN B-Diagnostic_procedure
also RB O
confirmed VBD O
alveolar JJ B-Biological_structure
hemorrhage NN B-Sign_symptom
relapse NN B-Detailed_description
. . O

Treatment NN O
with IN O
high JJ B-Dosage
- : I-Dosage
dose NN I-Dosage
methylprednisolone NN B-Medication
( ( O
1 CD B-Dosage
g NNS I-Dosage
daily RB I-Dosage
for IN O
3 CD B-Duration
consecutive JJ I-Duration
days NNS I-Duration
) ) O
and CC O
rituximab NN B-Medication
( ( O
375 CD B-Dosage
mg NN I-Dosage
/ NNP I-Dosage
m2 VBZ I-Dosage
weekly JJ I-Dosage
for IN O
4 CD B-Duration
weeks NNS I-Duration
) ) O
was VBD O
started VBN O
with IN O
rapid JJ O
resolution NN O
of IN O
urologic JJ B-Biological_structure
and CC O
pulmonary JJ B-Biological_structure
involvement NN B-Sign_symptom
but CC O
delayed JJ B-Detailed_description
and CC O
partial JJ B-Lab_value
improvement NN I-Lab_value
of IN O
renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
. . O

At IN O
a DT O
1 CD O
- : O
year NN O
follow SYM O
- : O
up RB O
, , O
the DT O
patient NN O
is VBZ O
alive JJ B-Sign_symptom
and CC O
under IN O
treatment NN O
with IN O
azathioprine NN B-Medication
( ( O
150 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
) ) O
and CC O
prednisone NN B-Medication
( ( O
15 CD B-Dosage
mg NNS I-Dosage
daily RB I-Dosage
) ) O
. . O

Renal JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
has VBZ O
markedly RB B-Lab_value
improved VBN I-Lab_value
( ( O
estimated VBN O
glomerular JJ B-Diagnostic_procedure
filtration NN I-Diagnostic_procedure
rate NN I-Diagnostic_procedure
94 CD B-Lab_value
mL NN I-Lab_value
/ NNP I-Lab_value
min NN I-Lab_value
) ) O
same JJ O
as IN O
gas NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
exchange NN I-Diagnostic_procedure
( ( O
pH JJ B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
42 CD I-Lab_value
, , O
PaO2 NNP B-Diagnostic_procedure
86 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
PaCO2 NNP B-Diagnostic_procedure
36 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
, , O
HCO3 NNP B-Diagnostic_procedure
- : O
23 CD B-Lab_value
mmol NN I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
SaO2 NNP B-Diagnostic_procedure
95 CD B-Lab_value
% NN I-Lab_value
) ) O
. . O

The DT O
patient NN O
signed VBD O
institutional JJ O
informed JJ O
consent NN O
form NN O
at IN O
the DT O
time NN O
of IN O
admission NN O
to TO O
hospitalization NN O
. . O

An DT O
approval NN O
by IN O
ethics NNS O
committee NN O
was VBD O
not RB O
necessary JJ O
because IN O
of IN O
the DT O
routine JJ O
health NN O
care NN O
. . O

-DOCSTART- NN -X-

A DT O
21 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
male NN O
presented VBN O
with IN O
a DT O
2 CD B-Duration
- : I-Duration
year NN I-Duration
history NN O
of IN O
progressive JJ B-Detailed_description
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
on IN O
exertion NN B-Detailed_description
and CC O
dry JJ B-Sign_symptom
cough NN I-Sign_symptom
. . O

At IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
auscultation NN B-Diagnostic_procedure
of IN O
the DT O
lungs NNS B-Biological_structure
has VBZ O
revealed VBN O
random NN B-Detailed_description
wheezes NNS B-Sign_symptom
and CC O
coarse JJ B-Sign_symptom
crackles NNS I-Sign_symptom
. . O

Cardiac JJ B-Biological_structure
auscultation NN B-Diagnostic_procedure
was VBD O
normal JJ O
, , O
and CC O
no DT O
cyanosis NN B-Sign_symptom
or CC O
peripheral JJ B-Sign_symptom
edema NN I-Sign_symptom
was VBD O
observed VBN O
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
smoking NN O
or CC O
previous JJ O
known VBN O
pulmonary JJ B-Disease_disorder
disease NN I-Disease_disorder
. . O

On IN O
routine JJ B-Detailed_description
blood NN B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
blood NN B-Diagnostic_procedure
counts NNS I-Diagnostic_procedure
and CC O
serum JJ B-Diagnostic_procedure
chemistries NNS I-Diagnostic_procedure
were VBD O
found VBN O
to TO O
be VB O
normal JJ B-Lab_value
. . O

Arterial NNP B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
and CC O
echocardiography NN B-Diagnostic_procedure
showed VBD O
no DT B-Lab_value
important JJ I-Lab_value
abnormalities NNS I-Lab_value
. . O

Pulmonary JJ B-Diagnostic_procedure
function NN I-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
( ( O
PFT NNP B-Diagnostic_procedure
) ) O
showed VBD O
a DT O
mild JJ B-Severity
restrictive JJ B-Sign_symptom
ventilatory NN I-Sign_symptom
defect NN I-Sign_symptom
, , O
with IN O
a DT O
reduced JJ B-Lab_value
total NN B-Diagnostic_procedure
lung NN I-Diagnostic_procedure
capacity NN I-Diagnostic_procedure
of IN O
79 CD B-Lab_value
% NN I-Lab_value
( ( O
5 CD B-Lab_value
. . I-Lab_value
94 CD I-Lab_value
L NNP I-Lab_value
) ) O
, , O
forced VBD B-Diagnostic_procedure
vital JJ I-Diagnostic_procedure
capacity NN I-Diagnostic_procedure
of IN O
80 CD B-Lab_value
% NN I-Lab_value
( ( O
4 CD B-Lab_value
. . I-Lab_value
18 CD I-Lab_value
L NNP I-Lab_value
) ) O
and CC O
a DT O
forced JJ B-Diagnostic_procedure
expiratory NN I-Diagnostic_procedure
volume NN I-Diagnostic_procedure
in IN I-Diagnostic_procedure
one CD I-Diagnostic_procedure
second NN I-Diagnostic_procedure
of IN O
83 CD B-Lab_value
% NN I-Lab_value
( ( O
3 CD B-Lab_value
. . I-Lab_value
72 CD I-Lab_value
L NNP I-Lab_value
) ) O
. . O

The DT O
sputum NN B-Biological_structure
was VBD O
negative JJ B-Lab_value
for IN O
acid JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
alcohol NN I-Diagnostic_procedure
resistant JJ I-Diagnostic_procedure
bacillus NN I-Diagnostic_procedure
and CC O
human JJ B-Diagnostic_procedure
immunodeficiency NN I-Diagnostic_procedure
virus NN I-Diagnostic_procedure
testing NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
as RB O
well RB O
. . O

The DT O
chest JJS B-Diagnostic_procedure
plain NN I-Diagnostic_procedure
films NNS I-Diagnostic_procedure
revealed VBD O
a DT O
diffuse NN B-Detailed_description
symmetric JJ B-Detailed_description
dense JJ B-Texture
bilateral JJ B-Biological_structure
micronodular NN B-Sign_symptom
pattern NN I-Sign_symptom
( ( O
Figure NNP O
1 CD O
) ) O
. . O

Based VBN O
on IN O
this DT O
finding NN O
, , O
HRCT NNP B-Diagnostic_procedure
scan NN I-Diagnostic_procedure
was VBD O
obtained VBN O
, , O
revealing VBG O
diffuse NN O
ground NN B-Sign_symptom
glass NN I-Sign_symptom
attenuation NN I-Sign_symptom
and CC O
septal JJ B-Sign_symptom
thickening NN I-Sign_symptom
, , O
more RBR O
pronounced JJ O
in IN O
lower JJR B-Biological_structure
pulmonary JJ I-Biological_structure
regions NNS I-Biological_structure
, , O
with IN O
calcifications NNS B-Sign_symptom
along IN O
the DT O
interlobar NN B-Biological_structure
septa NN I-Biological_structure
and CC O
subpleural JJ B-Biological_structure
regions NNS I-Biological_structure
. . O

Subpleural JJ B-Biological_structure
cysts NNS B-Sign_symptom
were VBD O
also RB O
noticed VBN O
( ( O
Figure NNP O
2 CD O
) ) O
. . O

The DT O
patient NN O
underwent NN O
a DT O
fiberoptic JJ B-Diagnostic_procedure
bronchoscopy NN I-Diagnostic_procedure
with IN O
bronchoalveolar JJ B-Diagnostic_procedure
lavage NN I-Diagnostic_procedure
and CC O
transbronchial JJ B-Biological_structure
lung NN B-Biological_structure
biopsy NN B-Diagnostic_procedure
. . O

The DT O
lavage NN B-Biological_structure
fluid NN I-Biological_structure
was VBD O
negative JJ B-Lab_value
for IN O
tuberculosis NN B-Diagnostic_procedure
or CC O
fungi NN B-Diagnostic_procedure
. . O

Microliths NNS B-Sign_symptom
were VBD O
not RB O
found VBN O
. . O

Histology NNP B-Diagnostic_procedure
revealed VBD O
round NN B-Shape
, , O
concentrically RB B-Detailed_description
laminated JJ I-Detailed_description
microliths NNS B-Sign_symptom
in IN O
the DT O
alveoli NN B-Biological_structure
associated VBN O
with IN O
slightly RB B-Severity
thickened VBN B-Sign_symptom
interstitial JJ I-Sign_symptom
septa NN I-Sign_symptom
, , O
consistent JJ O
with IN O
the DT O
diagnosis NN O
of IN O
PAM NNP B-Disease_disorder
. . O

-DOCSTART- NN -X-

A DT O
64 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
admitted VBN O
to TO O
the DT O
Department NNP B-Nonbiological_location
of IN I-Nonbiological_location
Gastroenterology NNP I-Nonbiological_location
of IN O
the DT O
Affiliated NNP B-Nonbiological_location
Hospital NNP I-Nonbiological_location
of IN I-Nonbiological_location
Qingdao NNP I-Nonbiological_location
University NNP I-Nonbiological_location
Medical NNP I-Nonbiological_location
College NNP I-Nonbiological_location
( ( I-Nonbiological_location
Qingdao NNP I-Nonbiological_location
, , I-Nonbiological_location
China NNP I-Nonbiological_location
) ) I-Nonbiological_location
due JJ O
to TO O
epigastric JJ B-Biological_structure
pains NNS B-Sign_symptom
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
no DT O
palpable JJ O
mass NN B-Sign_symptom
, , O
lymphadenopathy JJ B-Sign_symptom
, , O
or CC O
organomegaly NN B-Sign_symptom
. . O

On IN O
endoscopy NN B-Diagnostic_procedure
, , O
several JJ B-Detailed_description
submucosal JJ B-Biological_structure
lesions NNS B-Sign_symptom
were VBD O
identified VBN O
in IN O
the DT O
gastric JJ B-Biological_structure
antrum NN I-Biological_structure
and CC O
the DT O
duodenal JJ B-Biological_structure
bulb NN I-Biological_structure
( ( O
Fig NNP O
. . O
1 CD O
) ) O
. . O

Endoscopic NNP B-Diagnostic_procedure
ultrasonography NN I-Diagnostic_procedure
( ( O
EUS NNP B-Diagnostic_procedure
) ) O
( ( O
OLYMPUS NNP B-Detailed_description
EUS NNP I-Detailed_description
EU NNP I-Detailed_description
- : I-Detailed_description
ME2 NNP I-Detailed_description
, , O
Miniprobe NNP B-Detailed_description
sonography NN I-Detailed_description
) ) O
demonstrated VBD O
that IN O
the DT O
lesions NNS B-Sign_symptom
were VBD O
almost RB B-Distance
0 CD I-Distance
. . I-Distance
5 CD I-Distance
- : I-Distance
cm NN I-Distance
homogeneously RB O
hypoechoic JJ B-Detailed_description
neoplasms NNS B-Sign_symptom
originating VBG O
from IN O
the DT O
submucous JJ B-Biological_structure
layer NN I-Biological_structure
( ( O
Fig NNP O
. . O
2 CD O
) ) O
and CC O
the DT O
initial JJ O
diagnosis NN O
was VBD O
digestive JJ B-Biological_structure
neuroendocrine JJ B-Disease_disorder
tumors NNS I-Disease_disorder
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
revealed VBD O
enlarged JJ B-Sign_symptom
lymph NN I-Sign_symptom
nodes NNS I-Sign_symptom
in IN O
multiple JJ O
regions NNS O
( ( O
mediastinal JJ B-Biological_structure
, , O
retroperitoneal NN B-Biological_structure
, , O
mesenteric NN B-Biological_structure
, , O
and CC O
inguinal JJ B-Biological_structure
) ) O
and CC O
intracavitary JJ B-Detailed_description
nodules NNS B-Sign_symptom
in IN O
the DT O
duodenum NN B-Biological_structure
. . O

To TO O
reach VB O
a DT O
definitive JJ O
diagnosis NN O
, , O
the DT O
patient JJ O
underwent JJ O
repeat NN B-Detailed_description
EUS NNP B-Diagnostic_procedure
and CC O
biopsy NN B-Diagnostic_procedure
was VBD O
performed VBN O
. . O

On IN O
endoscopy NN B-Diagnostic_procedure
, , O
a DT O
2 CD B-Area
× NN I-Area
1 CD I-Area
- : I-Area
cm NN I-Area
columnar NN B-Sign_symptom
uplift NN I-Sign_symptom
in IN O
the DT O
terminal JJ B-Biological_structure
ileum NN I-Biological_structure
and CC O
multiple JJ B-Detailed_description
submucosal NN B-Biological_structure
lesions NNS B-Sign_symptom
in IN O
the DT O
rectum NN B-Biological_structure
were VBD O
identified VBN O
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

EUS NNP B-Diagnostic_procedure
revealed VBD O
that IN O
the DT O
lesions NNS B-Sign_symptom
in IN O
the DT O
terminal JJ B-Biological_structure
ileum NN I-Biological_structure
were VBD O
sized VBN O
1 CD B-Area
. . I-Area
6 CD I-Area
× JJ I-Area
1 CD I-Area
. . I-Area
2 CD I-Area
cm NN I-Area
and CC O
the DT O
lesions NNS B-Sign_symptom
in IN O
the DT O
rectum NN B-Biological_structure
were VBD O
sized VBN O
almost RB O
0 CD B-Area
. . I-Area
6 CD I-Area
× JJ I-Area
1 CD I-Area
. . I-Area
0 CD I-Area
cm NN I-Area
, , O
they PRP O
were VBD O
all DT O
homogeneously RB B-Detailed_description
hypoechoic JJ I-Detailed_description
and CC O
originated VBN B-Detailed_description
from IN I-Detailed_description
the DT I-Detailed_description
muscularis NN I-Detailed_description
mucosa NN I-Detailed_description
layer NN I-Detailed_description
. . O

Pathological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
of IN O
the DT O
biopsied JJ O
specimens NNS O
from IN O
the DT O
lesions NNS B-Sign_symptom
of IN O
the DT O
rectum NN B-Biological_structure
showed VBD O
diffuse RB O
lymphomatous JJ B-Detailed_description
proliferation NN I-Detailed_description
and CC O
dense NN B-Detailed_description
infiltration NN I-Detailed_description
by IN O
monomorphic JJ B-Biological_structure
, , I-Biological_structure
small JJ I-Biological_structure
cleaved VBD I-Biological_structure
cells NNS I-Biological_structure
with IN I-Biological_structure
irregularly JJ I-Biological_structure
shaped VBN I-Biological_structure
nuclei NN I-Biological_structure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

On IN O
immunohistochemical JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
, , O
the DT O
cells NNS O
were VBD O
positive JJ B-Lab_value
for IN O
cyclin NN B-Diagnostic_procedure
D1 NNP I-Diagnostic_procedure
, , O
CD20 NNP B-Diagnostic_procedure
, , O
CD21 NNP B-Diagnostic_procedure
, , O
SOX NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
11 CD I-Diagnostic_procedure
, , O
and CC O
Bcl NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
, , O
but CC O
negative JJ B-Lab_value
for IN O
CD3 NNP B-Diagnostic_procedure
and CC O
CD10 NNP B-Diagnostic_procedure
, , O
which WDT O
was VBD O
compatible JJ O
with IN O
the DT O
diagnosis NN O
of IN O
MCL NNP B-Disease_disorder
. . O

Ki NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
67 CD I-Diagnostic_procedure
staining NN I-Diagnostic_procedure
revealed VBD O
a DT O
proliferative JJ B-Lab_value
index NN I-Lab_value
of IN I-Lab_value
30 CD I-Lab_value
% NN I-Lab_value
. . O

Based VBN O
on IN O
these DT O
findings NNS O
, , O
the DT O
diagnosis NN O
of IN O
Ann NNP B-Lab_value
Arbor NNP I-Lab_value
stage NN I-Lab_value
IV NNP I-Lab_value
MCL NNP B-Disease_disorder
was VBD O
confirmed VBN O
. . O

The DT O
patient NN O
was VBD O
referred VBN O
for IN O
combination NN O
chemotherapy NN B-Medication
with IN O
rituximab NN B-Medication
, , O
cyclophosphamide NN B-Medication
, , O
doxorubicin NN B-Medication
, , O
vincristine NN B-Medication
, , O
and CC O
prednisone NN B-Medication
( ( O
R NNP B-Medication
- : I-Medication
CHOP NNP I-Medication
regimen NNS I-Medication
) ) O
. . O

The DT O
patient NN O
has VBZ O
been VBN O
in IN O
remission NN B-Sign_symptom
clinically RB O
. . O

-DOCSTART- NN -X-

A DT O
75 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
man NN O
was VBD O
referred VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
for IN O
the DT O
evaluation NN O
of IN O
dysphagia NN B-Sign_symptom
for IN O
9 CD B-Duration
months NNS I-Duration
. . O

He PRP O
had VBD O
associated VBN O
symptoms NNS O
of IN O
nausea NN B-Sign_symptom
and CC O
vomiting NN B-Sign_symptom
but CC O
denied VBD O
hematemesis NN B-Sign_symptom
, , O
hematochezia NN B-Sign_symptom
, , O
lethargy NN B-Sign_symptom
, , O
and CC O
dyspnea NN B-Sign_symptom
. . O

He PRP O
was VBD O
an DT O
active JJ O
smoker NN O
and CC O
consumed VBD O
alcohol NN O
for IN O
30 CD O
years NNS O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
no DT O
peripheral JJ B-Detailed_description
lymphadenopathy NN B-Sign_symptom
, , O
thyromegaly NN B-Sign_symptom
, , O
ascites VBZ B-Sign_symptom
, , O
or CC O
mass NN B-Sign_symptom
in IN O
the DT O
abdomen NNS B-Biological_structure
. . O

Laboratory NN B-Diagnostic_procedure
data NNS I-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
: : O
HBs NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
Ag NNP I-Diagnostic_procedure
negative JJ B-Lab_value
, , O
HIV NNP B-Diagnostic_procedure
negative JJ B-Lab_value
, , O
and CC O
syphilis RB B-Diagnostic_procedure
negative JJ B-Lab_value
. . O

Test NN O
for IN O
serum NN B-Diagnostic_procedure
antibody NN I-Diagnostic_procedure
against IN I-Diagnostic_procedure
Helicobacter NNP I-Diagnostic_procedure
pylori NN I-Diagnostic_procedure
was VBD O
negative JJ B-Lab_value
. . O

Chest NNP B-Biological_structure
computed VBD B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
was VBD O
notable JJ O
for IN O
a DT O
huge JJ B-Detailed_description
well NN B-Detailed_description
- : I-Detailed_description
circumscribed NN I-Detailed_description
and CC O
homogeneous JJ B-Detailed_description
cylindrical JJ B-Shape
mesenchymal NN B-Detailed_description
neoplasm NN B-Sign_symptom
measuring VBG O
15 CD B-Volume
. . I-Volume
5 CD I-Volume
× JJ I-Volume
5 CD I-Volume
. . I-Volume
9 CD I-Volume
× JJ I-Volume
4 CD I-Volume
. . I-Volume
0 CD I-Volume
cm NN I-Volume
in IN O
lower JJR B-Biological_structure
and CC I-Biological_structure
middle JJ I-Biological_structure
esophagus NN I-Biological_structure
with IN O
mild JJ B-Detailed_description
contrast NN I-Detailed_description
enhancement NN I-Detailed_description
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

CT NNP B-Diagnostic_procedure
revealed VBD O
no DT O
abnormalities NNS B-Sign_symptom
in IN O
the DT O
lungs NNS B-Biological_structure
, , O
heart NN B-Biological_structure
, , O
ribs NN B-Biological_structure
, , O
or CC O
mediastinum NN B-Biological_structure
. . O

Endoscopic NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
showed VBD O
a DT O
submucosal JJ B-Detailed_description
lesion NN B-Sign_symptom
in IN O
the DT O
esophagus NN B-Biological_structure
starting VBG O
at IN O
20 CD B-Distance
cm NN I-Distance
from IN I-Distance
the DT I-Distance
incisor NN I-Distance
teeth NN I-Distance
extending VBG O
up RP B-Biological_structure
to TO I-Biological_structure
the DT I-Biological_structure
cardia NN I-Biological_structure
( ( O
Fig NNP O
. . O
1B CD O
) ) O
. . O

Endoscopic NNP B-Diagnostic_procedure
ultrasonography NN I-Diagnostic_procedure
( ( O
EUS NNP B-Diagnostic_procedure
) ) O
revealed VBD O
hypoechoic JJ B-Detailed_description
lesion NN B-Sign_symptom
with IN O
a DT O
clear JJ B-Detailed_description
boundary NN I-Detailed_description
located VBN O
in IN O
the DT O
4th CD B-Detailed_description
layer NN I-Detailed_description
. . O

The DT O
mass NN O
appeared VBD O
as IN O
a DT O
benign JJ B-Sign_symptom
tumor NN I-Sign_symptom
and CC O
was VBD O
preoperatively RB O
diagnosed VBN O
as IN O
esophageal NN B-Disease_disorder
leiomyoma NN I-Disease_disorder
based VBN O
on IN O
chest NN O
CT NNP O
, , O
endoscopic NN O
examination NN O
, , O
and CC O
EUS NNP O
findings NNS O
. . O

Endoscopic NNP B-Detailed_description
mucosal NN B-Detailed_description
resection NN B-Therapeutic_procedure
or CC O
endoscopic NN B-Detailed_description
submucosal JJ B-Detailed_description
resection NN B-Therapeutic_procedure
was VBD O
not RB O
possible JJ O
because IN O
of IN O
large JJ O
size NN O
. . O

Hence NNP O
, , O
surgical JJ B-Detailed_description
resection NN B-Therapeutic_procedure
was VBD O
planned VBN O
and CC O
informed VBN O
written VBN O
consent NN O
was VBD O
taken VBN O
. . O

The DT O
patient JJ O
underwent NN O
thoracoscopic NN B-Detailed_description
- : I-Detailed_description
assisted JJ I-Detailed_description
resection NN B-Therapeutic_procedure
of IN O
the DT O
mass NN O
with IN O
gastroesophageal JJ B-Detailed_description
anastomosis NN B-Therapeutic_procedure
, , O
thoracic JJ B-Biological_structure
duct NN I-Biological_structure
ligation NN B-Therapeutic_procedure
, , O
and CC O
jejunostomy NN B-Therapeutic_procedure
. . O

Postoperative JJ B-Therapeutic_procedure
course NN I-Therapeutic_procedure
was VBD O
uneventful JJ B-Lab_value
. . O

Grossly RB O
, , O
a DT O
spindle NN B-Shape
shaped VBD I-Shape
lump NN B-Sign_symptom
measuring VBG O
14 CD B-Volume
× JJ I-Volume
3 CD I-Volume
. . I-Volume
5 CD I-Volume
× JJ I-Volume
2 CD I-Volume
. . I-Volume
5 CD I-Volume
cm NN I-Volume
, , O
was VBD O
observed VBN O
in IN O
the DT O
resected JJ O
esophagus NN B-Biological_structure
, , O
which WDT O
grew VBD O
into IN O
the DT O
esophageal JJ B-Biological_structure
lumen NNS I-Biological_structure
and CC O
blocked VBD B-Sign_symptom
most JJS O
of IN O
lumen NNS B-Biological_structure
. . O

This DT O
lump NN O
located VBN O
in IN O
the DT O
submucosa NN B-Biological_structure
was VBD O
covered VBN B-Detailed_description
with IN I-Detailed_description
intact JJ I-Detailed_description
mucosa NN I-Detailed_description
, , O
without IN O
erosion NN B-Sign_symptom
, , O
ulcer NN B-Disease_disorder
, , O
and CC O
hemorrhage NN B-Disease_disorder
. . O

Its PRP$ O
cut NN O
surface NN O
was VBD O
homogenously RB B-Color
white JJ I-Color
to TO O
grayish VB B-Color
- : I-Color
white JJ I-Color
in IN O
color NN O
. . O

Histological JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
using VBG O
hematoxylin NN B-Diagnostic_procedure
and CC O
eosin NN B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
revealed VBD O
that IN O
tumor NN O
was VBD O
covered VBN B-Detailed_description
with IN I-Detailed_description
intact JJ I-Detailed_description
squamous JJ I-Detailed_description
epithelium NN I-Detailed_description
, , O
arising VBG O
from IN B-Biological_structure
the DT I-Biological_structure
submucosal NN I-Biological_structure
layer NN I-Biological_structure
and CC O
expanding VBG O
in IN O
to TO O
the DT O
muscular JJ B-Biological_structure
layer NN I-Biological_structure
. . O

The DT O
tumor NN O
was VBD O
composed VBN B-Detailed_description
of IN I-Detailed_description
many JJ I-Detailed_description
nodules NNS I-Detailed_description
of IN I-Detailed_description
varying VBG I-Detailed_description
sizes NNS I-Detailed_description
separated VBN I-Detailed_description
by IN I-Detailed_description
collagen NN I-Detailed_description
fibers NNS I-Detailed_description
. . O

Numerous JJ B-Detailed_description
cytoplasm NN I-Detailed_description
- : I-Detailed_description
rich JJ I-Detailed_description
cells NNS I-Detailed_description
were VBD I-Detailed_description
observed VBN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
collagenous JJ I-Detailed_description
septations NNS I-Detailed_description
with IN I-Detailed_description
invasive JJ I-Detailed_description
growth NN I-Detailed_description
pattern NN I-Detailed_description
( ( O
Fig NNP O
. . O
2A CD O
- : O
C NN O
) ) O
. . O

The DT O
nodules NNS B-Detailed_description
were VBD I-Detailed_description
mainly RB I-Detailed_description
composed VBN I-Detailed_description
of IN I-Detailed_description
small JJ I-Detailed_description
to TO I-Detailed_description
mid VB I-Detailed_description
- : I-Detailed_description
sized VBN I-Detailed_description
centrocyte JJ I-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
or CC I-Detailed_description
monocyte VB I-Detailed_description
- : I-Detailed_description
like IN I-Detailed_description
cells NNS I-Detailed_description
arranged VBN I-Detailed_description
in IN I-Detailed_description
diffuse NN I-Detailed_description
pattern NN I-Detailed_description
. . O

These DT O
atypical JJ B-Detailed_description
lymphocytes NNS I-Detailed_description
possessed VBD O
clear JJ B-Detailed_description
boundary NN I-Detailed_description
, , O
pale JJ B-Detailed_description
cytoplasm NN I-Detailed_description
, , O
irregular JJ B-Detailed_description
nucleus NN I-Detailed_description
, , O
and CC O
occasional JJ B-Detailed_description
nucleolus NN I-Detailed_description
( ( O
Fig NNP O
. . O
2D CD O
) ) O
. . O

Mitosis NN B-Diagnostic_procedure
was VBD O
rare JJ B-Lab_value
. . O

No DT O
lymphoepithelial JJ B-Detailed_description
lesion NN B-Sign_symptom
was VBD O
recognized VBN O
in IN O
the DT O
lesion NN O
. . O

On IN O
immunohistochemical JJ B-Diagnostic_procedure
staining NN I-Diagnostic_procedure
, , O
epithelium NN B-Biological_structure
was VBD O
diffusely RB B-Lab_value
positive JJ I-Lab_value
for IN O
cytokeratin NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3A CD O
) ) O
, , O
and CC O
the DT O
tumor NN O
cells NNS O
were VBD O
diffusely RB B-Lab_value
positive JJ I-Lab_value
for IN O
cluster NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
differentiation NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
CD NN I-Diagnostic_procedure
) ) I-Diagnostic_procedure
20 CD I-Diagnostic_procedure
, , O
paired VBD B-Diagnostic_procedure
box NN I-Diagnostic_procedure
5 CD I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3B CD O
) ) O
, , O
and CC O
B NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
cell NN I-Diagnostic_procedure
lymphoma NN I-Diagnostic_procedure
( ( I-Diagnostic_procedure
Bcl NNP I-Diagnostic_procedure
) ) I-Diagnostic_procedure
- : I-Diagnostic_procedure
2 CD I-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3D CD O
) ) O
. . O

Small JJ B-Biological_structure
deposits NNS I-Biological_structure
of IN I-Biological_structure
tumor NN I-Biological_structure
cells NNS I-Biological_structure
, , O
which WDT O
were VBD O
distributed VBN O
mainly RB B-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
collagen NN I-Detailed_description
fibers NNS I-Detailed_description
, , O
were VBD O
positive JJ B-Lab_value
for IN O
multiple JJ B-Diagnostic_procedure
myeloma NN I-Diagnostic_procedure
oncogene NN I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
, , O
CD138 NNP B-Diagnostic_procedure
, , O
and CC O
CD43 NNP B-Diagnostic_procedure
. . O

Several JJ B-Biological_structure
tumor NN I-Biological_structure
cells NNS I-Biological_structure
were VBD O
also RB O
positive JJ B-Lab_value
for IN O
CD30 NNP B-Diagnostic_procedure
. . O

Small JJ B-Biological_structure
lymphocytes NNS I-Biological_structure
were VBD O
positive JJ B-Lab_value
for IN O
CD3 NNP B-Diagnostic_procedure
and CC O
CD5 NNP B-Diagnostic_procedure
. . O

Follicular NNP B-Biological_structure
dendritic JJ I-Biological_structure
cells NNS I-Biological_structure
were VBD O
positive JJ B-Lab_value
for IN O
CD21 NNP B-Diagnostic_procedure
and CC O
CD23 NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3C CD O
) ) O
. . O

All DT B-Biological_structure
cells NNS I-Biological_structure
were VBD O
negative JJ B-Lab_value
for IN O
CyclinD1 NNP B-Diagnostic_procedure
, , O
CD10 NNP B-Diagnostic_procedure
, , O
Bcl NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
6 CD I-Diagnostic_procedure
, , O
and CC O
B NNP B-Diagnostic_procedure
lymphocyte NN I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
activation NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
OCT NNP I-Diagnostic_procedure
binding VBG I-Diagnostic_procedure
protein RB I-Diagnostic_procedure
1 CD I-Diagnostic_procedure
. . O

These DT O
follicular JJ O
dendritic NN O
cells NNS O
were VBD O
arranged VBN O
in IN O
nodules NNS O
in IN O
which WDT O
the DT O
tumor NN O
cells NNS O
were VBD O
relatively RB O
evenly RB O
distributed VBN O
. . O

This DT O
pattern NN O
was VBD O
suggestive JJ O
of IN O
follicular JJ O
colonizations NNS O
seen VBN O
in IN O
MALT NNP B-Disease_disorder
lymphoma NN I-Disease_disorder
. . O

In IN O
this DT O
case NN O
, , O
gene NN B-Diagnostic_procedure
rearragements NNS I-Diagnostic_procedure
and CC I-Diagnostic_procedure
clonality NN I-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
of IN O
immunoglobulin JJ B-Diagnostic_procedure
heavy JJ I-Diagnostic_procedure
chain NN I-Diagnostic_procedure
gene NN I-Diagnostic_procedure
, , O
kappa VB B-Diagnostic_procedure
light NN I-Diagnostic_procedure
chain NN I-Diagnostic_procedure
gene NN I-Diagnostic_procedure
, , O
and CC O
lambda JJ B-Diagnostic_procedure
light NN I-Diagnostic_procedure
chain NN I-Diagnostic_procedure
gene NN I-Diagnostic_procedure
was VBD O
performed VBN O
using VBG O
the DT O
IdentiCloneTM NNP B-Detailed_description
IGH NNP I-Detailed_description
/ NNP I-Detailed_description
IGK NNP I-Detailed_description
/ NNP I-Detailed_description
IGL NNP I-Detailed_description
Gene NNP I-Detailed_description
Clonality NNP I-Detailed_description
Assay NNP I-Detailed_description
( ( O
InVivoScribe NNP B-Detailed_description
Technologies NNPS I-Detailed_description
, , I-Detailed_description
CA NNP I-Detailed_description
) ) O
. . O

On IN O
monoclonal JJ O
gene NN O
rearrangement NN O
, , O
1 CD B-Lab_value
band NN I-Lab_value
appeared VBD I-Lab_value
within IN I-Lab_value
150 CD I-Lab_value
to TO I-Lab_value
175 CD I-Lab_value
base NN I-Lab_value
pairs NN I-Lab_value
( ( O
bp NN O
) ) O
in IN O
heavy NN O
chain NN O
gene NN O
, , O
2 CD B-Lab_value
discrete JJ I-Lab_value
bands NNS I-Lab_value
within IN I-Lab_value
225 CD I-Lab_value
to TO I-Lab_value
250 CD I-Lab_value
bp NN I-Lab_value
in IN O
kappa NN O
light NN O
chain NN O
gene NN O
, , O
and CC O
1 CD B-Lab_value
band NN I-Lab_value
within IN I-Lab_value
125 CD I-Lab_value
to TO I-Lab_value
150 CD I-Lab_value
bp NN I-Lab_value
in IN O
lambda JJ O
light NN O
chain NN O
gene NN O
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

In IN O
addition NN O
, , O
no DT O
Epstein NNP B-Disease_disorder
- : I-Disease_disorder
Barr NNP I-Disease_disorder
virus NN I-Disease_disorder
was VBD O
observed VBN O
in IN O
this DT O
lymphoma NN O
on IN O
in IN B-Diagnostic_procedure
situ JJ I-Diagnostic_procedure
hybridization NN I-Diagnostic_procedure
using VBG O
the DT O
EB NNP B-Detailed_description
virus NN I-Detailed_description
- : I-Detailed_description
encoded VBD I-Detailed_description
small JJ I-Detailed_description
RNA NNP I-Detailed_description
( ( O
Fig NNP O
. . O
3E CD O
, , O
F NNP O
) ) O
. . O

Based VBN O
on IN O
the DT O
clinical JJ O
data NNS O
, , O
pathological JJ O
, , O
immunohistochemical JJ O
, , O
and CC O
gene NN O
rearragements NNS O
analysis NN O
, , O
final JJ O
diagnosis NN O
of IN O
primary JJ B-Detailed_description
esophageal JJ B-Biological_structure
MALT NNP B-Disease_disorder
lymphoma NN I-Disease_disorder
was VBD O
made VBN O
. . O

After IN O
the DT O
surgical JJ B-Detailed_description
resection NN B-Therapeutic_procedure
, , O
no DT O
additional JJ O
therapy NN B-Therapeutic_procedure
in IN O
the DT O
form NN O
of IN O
chemotherapy NN B-Medication
or CC O
radiotherapy NN B-Therapeutic_procedure
was VBD O
administered VBN O
. . O

Over IN O
the DT O
8 CD B-Duration
months NNS I-Duration
of IN O
follow JJ O
- : O
up RB O
, , O
no DT O
evidence NN O
of IN O
recurrence NN B-Sign_symptom
or CC O
metastases NNS B-Sign_symptom
was VBD O
found VBN O
on IN O
CT NNP B-Diagnostic_procedure
and CC O
the DT O
patient NN O
has VBZ O
been VBN O
asymptomatic JJ B-Sign_symptom
. . O

Ethical JJ O
approval NN O
for IN O
this DT O
study NN O
was VBD O
obtained VBN O
from IN O
Medical NNP O
Ethics NNP O
Committee NNP O
of IN O
the DT O
Third NNP O
Affiliated NNP O
Hospital NNP O
, , O
the DT O
Third NNP O
Military NNP O
Medical NNP O
University NNP O
. . O

Written NNP O
informed VBD O
consent NN O
was VBD O
obtained VBN O
from IN O
the DT O
patient NN O
for IN O
the DT O
publication NN O
of IN O
this DT O
case NN O
report NN O
and CC O
the DT O
accompanying NN O
images NNS O
. . O

-DOCSTART- NN -X-

n IN O
March NNP O
2015 CD O
, , O
a DT O
62 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
was VBD O
admitted VBN O
to TO O
our PRP$ O
hospital NN B-Nonbiological_location
. . O

She PRP O
complained VBD O
of IN O
progressive JJ B-Detailed_description
visual JJ B-Sign_symptom
disturbance NN I-Sign_symptom
, , O
which WDT O
began VBD O
about IN O
4 CD O
years NNS O
ago RB O
and CC O
was VBD O
treated VBN O
as IN O
cataract NN B-Disease_disorder
in IN O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
, , O
but CC O
no DT O
relief NN B-Sign_symptom
was VBD O
seen VBN O
. . O

On IN O
the DT O
contrary JJ O
, , O
the DT O
symptoms NNS B-Sign_symptom
aggravated VBD O
half PDT O
a DT O
year NN O
ago RB O
, , O
together RB O
with IN O
headache NN B-Sign_symptom
, , O
left VBD B-Biological_structure
eye NN I-Biological_structure
pain NN B-Sign_symptom
, , O
tearing VBG B-Sign_symptom
and CC O
increased JJ O
secretions NNS B-Sign_symptom
, , O
and CC O
the DT O
computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
scan NN O
of IN O
the DT O
brain NN B-Biological_structure
in IN O
local JJ B-Nonbiological_location
hospital NN I-Nonbiological_location
showed VBD O
a DT O
sellar JJ B-Biological_structure
region NN I-Biological_structure
lesion NN B-Sign_symptom
. . O

Besides IN O
, , O
2 CD O
years NNS O
earlier RBR O
, , O
the DT O
patient JJ O
underwent JJ O
resection NN B-Therapeutic_procedure
of IN O
melanoma NN B-Disease_disorder
in IN O
the DT O
left NN B-Biological_structure
heel NN I-Biological_structure
( ( O
T2N0M0 NNP B-Lab_value
, , O
ki67 VBD B-Lab_value
3 CD I-Lab_value
- : I-Lab_value
5 CD I-Lab_value
% NN I-Lab_value
, , O
Stage NNP B-Lab_value
II NNP I-Lab_value
) ) O
, , O
followed VBN O
by IN O
resection NN B-Therapeutic_procedure
of IN O
the DT O
recurred JJ B-Detailed_description
melanoma NN B-Disease_disorder
nearby IN B-Biological_structure
the DT I-Biological_structure
primary JJ I-Biological_structure
site NN I-Biological_structure
15 CD O
months NNS O
later RB O
( ( O
T3N3M0 NNP B-Lab_value
, , O
Stage NNP B-Lab_value
III NNP I-Lab_value
) ) O
, , O
without IN O
lymphadenectomy NN B-Therapeutic_procedure
. . O

She PRP O
had VBD O
no DT O
family NN O
history NN O
of IN O
melanoma NN O
. . O

On IN O
physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
had VBD O
bilateral JJ B-Detailed_description
temporal JJ B-Detailed_description
hemianopsia NN B-Sign_symptom
, , O
the DT O
right JJ B-Diagnostic_procedure
finger NN I-Diagnostic_procedure
counting NN I-Diagnostic_procedure
was VBD O
1 CD B-Lab_value
m NN I-Lab_value
, , O
and CC O
the DT O
left JJ B-Diagnostic_procedure
finger NN I-Diagnostic_procedure
counting NN I-Diagnostic_procedure
was VBD O
no DT B-Lab_value
more JJR I-Lab_value
than IN I-Lab_value
0 CD I-Lab_value
. . I-Lab_value
5 CD I-Lab_value
m NN I-Lab_value
. . O

Enlarged NNP B-Sign_symptom
lymph NN B-Biological_structure
nodes NNS I-Biological_structure
were VBD O
palpable JJ O
in IN O
the DT O
right JJ B-Biological_structure
groin NN I-Biological_structure
. . O

On IN O
ophthalmologic JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
, , O
the DT O
patient NN O
had VBD O
right JJ B-Diagnostic_procedure
vision NN I-Diagnostic_procedure
of IN O
0 CD B-Lab_value
. . I-Lab_value
4 CD I-Lab_value
and CC O
left VBD B-Diagnostic_procedure
vision NN I-Diagnostic_procedure
of IN O
0 CD B-Lab_value
. . I-Lab_value
08 CD I-Lab_value
, , O
with IN O
the DT O
same JJ O
intraocular JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
15 CD B-Lab_value
mm NN I-Lab_value
Hg NNP I-Lab_value
bilaterally RB B-Detailed_description
. . O

The DT O
optometry NN B-Diagnostic_procedure
found VBD O
the DT O
right JJ B-Biological_structure
eye NN I-Biological_structure
of IN O
+6 NNP B-Lab_value
. . I-Lab_value
00DS CD I-Lab_value
/ JJ I-Lab_value
+0 NNP I-Lab_value
. . I-Lab_value
25DC CD I-Lab_value
∗ JJ I-Lab_value
65 CD I-Lab_value
° NN I-Lab_value
and CC O
the DT O
left JJ B-Biological_structure
eye NN I-Biological_structure
of IN O
+6 NNP B-Lab_value
. . I-Lab_value
25DS CD I-Lab_value
/ JJ I-Lab_value
+0 NNP I-Lab_value
. . I-Lab_value
50DC CD I-Lab_value
∗ JJ I-Lab_value
20 CD I-Lab_value
° NN I-Lab_value
. . O

The DT O
patient NN O
had VBD O
maculopathy NN B-Disease_disorder
of IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
and CC O
optic JJ B-Disease_disorder
atrophy NN I-Disease_disorder
of IN O
the DT O
left NN B-Biological_structure
eye NN I-Biological_structure
. . O

Light NNP B-Diagnostic_procedure
reflex NN I-Diagnostic_procedure
and CC O
eye NN B-Diagnostic_procedure
movement NN I-Diagnostic_procedure
of IN O
both DT B-Biological_structure
eyes NNS I-Biological_structure
were VBD O
normal JJ B-Lab_value
. . O

CT NNP B-Diagnostic_procedure
scans NNS O
of IN O
the DT O
brain NN B-Biological_structure
parenchyma NN I-Biological_structure
, , O
orbital JJ B-Biological_structure
, , O
and CC O
chest JJS B-Biological_structure
were VBD O
unremarkable JJ B-Lab_value
. . O

CT NNP B-Diagnostic_procedure
scan JJ O
and CC O
ultrasound JJ B-Diagnostic_procedure
examination NN O
of IN O
the DT O
abdomen NNS B-Biological_structure
showed VBD O
hepatic JJ B-Biological_structure
portal NN I-Biological_structure
and CC O
retroperitoneal JJ B-Biological_structure
lymphadenectasis NN B-Sign_symptom
and CC O
enlarged VBD B-Sign_symptom
left VBN B-Biological_structure
lobe NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
liver NN I-Biological_structure
with IN O
substantial JJ B-Severity
placeholder NN B-Detailed_description
lesions NNS B-Sign_symptom
. . O

Ultrasound IN B-Diagnostic_procedure
examination NN O
of IN O
bilateral JJ B-Detailed_description
inguinal JJ B-Biological_structure
lymph NN I-Biological_structure
nodes NNS I-Biological_structure
discovered VBD O
multiple JJ B-Detailed_description
low JJ B-Sign_symptom
echo NN I-Sign_symptom
light NN I-Sign_symptom
groups NNS I-Sign_symptom
, , O
the DT O
largest JJS B-Distance
of IN I-Distance
which WDT I-Distance
was VBD I-Distance
31 CD I-Distance
mm NN I-Distance
in IN O
diameter NN O
, , O
with IN O
hilus NN B-Detailed_description
of IN I-Detailed_description
the DT I-Detailed_description
echo NN I-Detailed_description
and CC O
asymmetrical JJ B-Detailed_description
thickening NN B-Sign_symptom
of IN O
the DT O
skin NN B-Biological_structure
. . O

CT NNP B-Diagnostic_procedure
scan NN O
of IN O
sellar JJ B-Biological_structure
region NN I-Biological_structure
revealed VBD O
a DT O
crumby JJ B-Texture
mass NN B-Sign_symptom
, , O
protruding VBG O
out IN O
of IN O
the DT O
sphenoid JJ B-Biological_structure
sinus NN I-Biological_structure
, , O
with IN O
obscure JJ B-Detailed_description
boundary JJ I-Detailed_description
and CC O
bone JJ B-Detailed_description
destruction NN I-Detailed_description
. . O

And CC O
the DT O
average JJ B-Detailed_description
CT NNP B-Diagnostic_procedure
value NN I-Diagnostic_procedure
of IN O
the DT O
mass NN B-Sign_symptom
was VBD O
46 CD B-Lab_value
HU NNP I-Lab_value
. . O

Sellar JJ B-Biological_structure
region NN I-Biological_structure
magnetic JJ B-Diagnostic_procedure
resonance NN I-Diagnostic_procedure
imaging NN I-Diagnostic_procedure
( ( O
MRI NNP B-Diagnostic_procedure
) ) O
revealed VBD O
a DT O
round JJ B-Shape
mass NN B-Sign_symptom
of IN O
30 CD B-Distance
mm NNS I-Distance
in IN O
diameter NN O
in IN O
the DT O
enlarged JJ B-Biological_structure
sellae NN I-Biological_structure
( ( O
Fig NNP O
. . O
1A CD O
, , O
B NNP O
) ) O
. . O

The DT O
mass NN O
showed VBD O
isointense NN B-Sign_symptom
in IN O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted VBD I-Diagnostic_procedure
images NNS I-Diagnostic_procedure
( ( O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
WI NNP I-Diagnostic_procedure
) ) O
and CC O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
weighted VBD I-Diagnostic_procedure
images NNS I-Diagnostic_procedure
( ( O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
WI NNP I-Diagnostic_procedure
) ) O
, , O
with IN O
homogeneous JJ B-Detailed_description
enhancement NN B-Sign_symptom
after IN O
Gadolinium NNP B-Detailed_description
- : I-Detailed_description
DTPA NNP I-Detailed_description
injection NN I-Detailed_description
, , O
and CC O
dural JJ B-Detailed_description
tail NN I-Detailed_description
sign NN I-Detailed_description
was VBD O
seen VBN O
. . O

Small JJ O
foci NN O
inside IN O
the DT O
tumor NN O
showed VBD O
hyperintense JJ B-Sign_symptom
signals NNS I-Sign_symptom
in IN O
T1 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
WI NNP I-Diagnostic_procedure
and CC O
hypointense NN B-Sign_symptom
signals NNS I-Sign_symptom
in IN O
T2 NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
WI NNP I-Diagnostic_procedure
, , O
without IN B-Detailed_description
enhancement NN I-Detailed_description
. . O

And CC O
it PRP O
was VBD O
seen VBN O
that IN O
the DT O
mass NN O
penetrated VBD O
meninges NNS B-Biological_structure
, , O
surrounded VBD O
the DT O
left JJ B-Biological_structure
internal JJ I-Biological_structure
carotid NN I-Biological_structure
artery NN I-Biological_structure
, , O
and CC O
was VBD O
blurred VBN O
with IN O
the DT O
left JJ B-Biological_structure
optic JJ I-Biological_structure
nerve NN I-Biological_structure
. . O

Pituitary JJ B-Biological_structure
stalk NN I-Biological_structure
became VBD O
shorter JJR B-Sign_symptom
with IN O
a DT O
right JJ B-Detailed_description
displacement NN I-Detailed_description
. . O

Laboratory JJ B-Diagnostic_procedure
findings NNS I-Diagnostic_procedure
revealed VBD O
increased JJ B-Lab_value
levels NNS O
of IN O
prolactin NN B-Diagnostic_procedure
( ( O
119 CD B-Lab_value
. . I-Lab_value
08 CD I-Lab_value
μg JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
normal JJ O
range NN O
5 CD O
. . O
99 CD O
- : O
30 CD O
. . O
04 CD O
μg JJ O
/ NNP O
L NNP O
) ) O
and CC O
cortisol NN B-Diagnostic_procedure
( ( O
677 CD B-Lab_value
. . I-Lab_value
10 CD I-Lab_value
nmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
normal JJ O
range NN O
118 CD O
. . O
60 CD O
- : O
618 CD O
. . O
00 CD O
nmol JJ O
/ NNP O
L NNP O
) ) O
and CC O
decreased JJ B-Lab_value
levels NNS O
of IN O
free JJ B-Diagnostic_procedure
thyroxine NN I-Diagnostic_procedure
( ( O
FT4 NNP B-Diagnostic_procedure
) ) O
( ( O
6 CD B-Lab_value
. . I-Lab_value
04 CD I-Lab_value
pmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
normal JJ O
range NN O
12 CD O
. . O
00 CD O
- : O
22 CD O
. . O
00 CD O
pmol JJ O
/ NNP O
L NNP O
) ) O
and CC O
free JJ B-Diagnostic_procedure
triiodothyronine NN I-Diagnostic_procedure
( ( O
FT3 NNP B-Diagnostic_procedure
) ) O
( ( O
2 CD B-Lab_value
. . I-Lab_value
09 CD I-Lab_value
pmol JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
, , O
normal JJ O
range NN O
3 CD O
. . O
50 CD O
- : O
6 CD O
. . O
50 CD O
pmol JJ O
/ NNP O
L NNP O
) ) O
. . O

The DT O
patient NN O
was VBD O
diagnosed VBN O
with IN O
a DT O
giant JJ B-Detailed_description
prolactinoma NN B-Disease_disorder
. . O

The DT O
patient JJ O
underwent JJ O
transnasal NN B-Detailed_description
transsphenoidal NN B-Detailed_description
surgery NN B-Therapeutic_procedure
to TO O
remove VB O
the DT O
tumor NN O
and CC O
relieve VB O
the DT O
compression NN O
of IN O
the DT O
optic JJ O
nerve NN O
. . O

Intraoperatively RB O
, , O
it PRP O
was VBD O
seen VBN O
that IN O
the DT O
tumor NN B-Sign_symptom
invaded VBD O
and CC O
filled VBD O
the DT O
left JJ B-Biological_structure
interval NN I-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
sphenoid JJ I-Biological_structure
sinus NN I-Biological_structure
, , O
and CC O
part NN O
of IN O
bone NN B-Biological_structure
in IN I-Biological_structure
sellar JJ I-Biological_structure
floor NN I-Biological_structure
and CC O
left VBD B-Biological_structure
side NN I-Biological_structure
parasellar NN I-Biological_structure
was VBD O
destroyed VBN B-Sign_symptom
and CC O
absorbed VBN B-Sign_symptom
. . O

A DT O
little JJ B-Detailed_description
normal JJ I-Detailed_description
pituitary JJ I-Detailed_description
tissue NN I-Detailed_description
was VBD I-Detailed_description
seen VBN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
top JJ I-Detailed_description
right NN I-Detailed_description
of IN O
tumor NN O
in IN O
the DT O
sellar JJ B-Biological_structure
turcica NN I-Biological_structure
. . O

The DT O
tumor NN O
was VBD O
reddish JJ B-Color
black JJ I-Color
with IN O
extremely RB B-Detailed_description
rich JJ I-Detailed_description
blood NN I-Detailed_description
supply NN I-Detailed_description
and CC O
had VBD O
close JJ B-Detailed_description
adhesion NN I-Detailed_description
to TO I-Detailed_description
the DT I-Detailed_description
surrounding NN I-Detailed_description
structure NN I-Detailed_description
. . O

The DT O
texture NN O
in IN O
the DT O
center NN O
of IN O
the DT O
tumor NN O
was VBD O
soft JJ B-Texture
and CC O
much JJ B-Texture
tougher JJR I-Texture
over IN I-Texture
the DT I-Texture
rim NN I-Texture
. . O

Intraoperative JJ B-Detailed_description
frozen SYM B-Diagnostic_procedure
- : I-Diagnostic_procedure
section NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
found VBD O
melanin NN B-Sign_symptom
granules NNS I-Sign_symptom
, , O
and CC O
it PRP O
was VBD O
considered VBN O
to TO O
be VB O
malignant JJ B-Disease_disorder
melanoma NN I-Disease_disorder
or CC O
meningioma NN B-Disease_disorder
. . O

The DT O
tumor NN O
cells NNS O
were VBD O
composed VBN O
of IN O
eosinophilic JJ B-Detailed_description
staining VBG I-Detailed_description
epithelial JJ I-Detailed_description
cells NNS I-Detailed_description
. . O

Most JJS O
of IN O
cell NN B-Diagnostic_procedure
nuclei NNS I-Diagnostic_procedure
were VBD O
round VBN B-Shape
, , O
a DT O
few JJ O
were VBD O
reniform JJ B-Lab_value
and CC O
hippocrepiform NN B-Lab_value
with IN O
evident JJ B-Lab_value
nucleoli NNS B-Diagnostic_procedure
, , O
and CC O
nuclear JJ B-Diagnostic_procedure
fission NN I-Diagnostic_procedure
was VBD O
seen VBN B-Lab_value
. . O

The DT O
tumor NN O
showed VBD O
no DT O
evidence NN O
of IN O
necrosis NN B-Sign_symptom
( ( O
Fig NNP O
. . O
2 CD O
) ) O
. . O

The DT O
tumor NN O
was VBD O
immunopositive JJ B-Lab_value
focally RB B-Detailed_description
for IN O
melanoma NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
specific JJ I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
such JJ O
as IN O
S NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
100 CD I-Diagnostic_procedure
, , O
HMB45 NNP B-Diagnostic_procedure
, , O
and CC O
Vimentin NNP B-Diagnostic_procedure
, , O
and CC O
immunopositive JJ B-Lab_value
for IN O
neuroendocrine JJ B-Diagnostic_procedure
tumor NN I-Diagnostic_procedure
markers NNS I-Diagnostic_procedure
such JJ O
as IN O
CgA NNP B-Diagnostic_procedure
and CC O
Syn NNP B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

The DT O
Ki67 NNP B-Diagnostic_procedure
index NN I-Diagnostic_procedure
was VBD O
3 CD B-Lab_value
% NN I-Lab_value
to TO I-Lab_value
5 CD I-Lab_value
% NN I-Lab_value
; : O
it PRP O
was VBD O
higher RBR B-Lab_value
in IN O
metastatic JJ B-Detailed_description
melanoma NN I-Detailed_description
than IN I-Detailed_description
in IN I-Detailed_description
the DT I-Detailed_description
adenomatous JJ I-Detailed_description
component NN I-Detailed_description
. . O

Taken VBN O
the DT O
melanoma JJ O
history NN O
and CC O
suspected VBD O
lymph JJ O
node NN O
and CC O
hepatic JJ O
metastasis NN O
into IN O
consideration NN O
, , O
the DT O
patient NN O
was VBD O
diagnosised VBN O
with IN O
MMPA NNP B-Disease_disorder
. . O

After IN O
surgery NN O
, , O
significant JJ O
relief NN B-Lab_value
was VBD O
seen VBN O
in IN O
visual JJ B-Diagnostic_procedure
field NN I-Diagnostic_procedure
and CC O
headache NN B-Sign_symptom
, , O
and CC O
the DT O
level NN O
of IN O
prolactin NN B-Diagnostic_procedure
, , O
cortisol NN B-Diagnostic_procedure
, , O
and CC O
FT4 NNP B-Diagnostic_procedure
returned VBD O
to TO O
normal JJ B-Lab_value
with IN O
hormone JJ B-Medication
replacement NN I-Medication
therapy NN I-Medication
. . O

Because IN O
the DT O
focal JJ O
liver NN O
lesions NNS O
and CC O
lymphadenectasis NN O
did VBD O
not RB O
cause VB O
much JJ O
discomfort NN B-Sign_symptom
, , O
the DT O
patient NN O
refused VBD O
any DT O
further JJ O
surgical JJ B-Therapeutic_procedure
intervention NN I-Therapeutic_procedure
or CC O
other JJ O
treatment NN O
. . O

She PRP O
was VBD O
discharged VBN O
from IN O
the DT O
hospital NN B-Nonbiological_location
immediately RB O
and CC O
was VBD O
disease JJ B-Disease_disorder
free JJ O
until IN O
2 CD O
months NNS O
after IN O
the DT O
third JJ O
surgery NN O
. . O

The DT O
patient NN O
successively RB O
found VBD O
new JJ O
melanoma NN B-Disease_disorder
metastatic JJ B-Sign_symptom
sites NNS I-Sign_symptom
in IN O
the DT O
skin NN B-Biological_structure
of IN I-Biological_structure
lower JJR I-Biological_structure
left NN I-Biological_structure
leg NN I-Biological_structure
, , O
knees NNS O
, , O
the DT O
upper JJ B-Biological_structure
left NN I-Biological_structure
leg NN I-Biological_structure
, , O
the DT O
left NN B-Biological_structure
groin NN I-Biological_structure
and CC O
the DT O
right JJ B-Biological_structure
groin NN I-Biological_structure
, , O
and CC O
the DT O
right JJ B-Biological_structure
leg NN I-Biological_structure
. . O

At IN O
the DT O
follow NN O
- : O
up RB O
in IN O
late JJ O
January NNP O
2016 CD O
, , O
the DT O
patient NN O
could MD O
not RB O
walk VB B-Activity
and CC O
live VB B-Activity
by IN I-Activity
herself PRP I-Activity
and CC O
was VBD O
depressed VBN B-Disease_disorder
. . O

At IN O
the DT O
latest JJS O
follow NN O
- : O
up RB O
, , O
in IN O
late JJ O
January NNP O
, , O
2017 CD O
, , O
the DT O
patient NN O
was VBD O
alive JJ B-Sign_symptom
with IN O
worse JJR O
symptoms NNS B-Sign_symptom
, , O
she PRP O
had VBD O
sensory JJ B-Sign_symptom
deficits NNS I-Sign_symptom
of IN O
both DT B-Biological_structure
legs NNS I-Biological_structure
, , O
which WDT O
could MD B-Sign_symptom
not RB I-Sign_symptom
move VB I-Sign_symptom
, , O
hyperalgesia NN B-Sign_symptom
of IN O
hands NNS B-Biological_structure
and CC O
mouth NN B-Biological_structure
, , O
impaired JJ B-Sign_symptom
intelligence NN I-Sign_symptom
, , O
but CC O
she PRP O
lived VBD O
well RB O
with IN O
the DT O
disease NN O
by IN O
careful JJ O
nursing NN O
of IN O
her PRP$ O
daughter NN O
. . O

-DOCSTART- NN -X-

A DT O
23 CD B-Age
year NN I-Age
old JJ I-Age
white JJ O
male NN O
with IN O
a DT O
4 CD B-Duration
year NN I-Duration
history NN O
of IN O
Crohn NNP B-Disease_disorder
` `` I-Disease_disorder
s JJ I-Disease_disorder
disease NN I-Disease_disorder
presented VBN O
with IN O
an DT O
acute JJ O
two CD B-Duration
day NN I-Duration
history NN O
of IN O
malaise NN B-Sign_symptom
, , O
fever NN B-Sign_symptom
, , O
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
, , O
vomiting VBG B-Sign_symptom
and CC O
stomal JJ B-Biological_structure
diarrhoea NN B-Sign_symptom
. . O

He PRP O
complained VBD O
of IN O
joint JJ B-Biological_structure
pains NNS B-Sign_symptom
affecting VBG O
the DT O
shoulders NNS B-Biological_structure
, , O
elbows NNS B-Biological_structure
, , O
wrists NNS B-Biological_structure
, , O
metacarpophalangeals NNS B-Biological_structure
, , O
knees NNS B-Biological_structure
and CC O
ankles NNS B-Biological_structure
. . O

There EX O
was VBD O
also RB O
a DT O
rash NN B-Sign_symptom
on IN O
the DT O
elbows NNS B-Biological_structure
, , O
ankles NNS B-Biological_structure
and CC O
feet NNS B-Biological_structure
, , O
which WDT O
began VBD O
as IN O
erythematous JJ B-Detailed_description
macules NNS B-Sign_symptom
and CC O
evolved VBD O
to TO O
vesico VB B-Detailed_description
- : I-Detailed_description
pustular JJ I-Detailed_description
lesions NNS B-Sign_symptom
followed VBN O
by IN O
crusting VBG B-Sign_symptom
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
sexual JJ O
exposure NN O
or CC O
any DT O
intercurrent JJ O
infection NN B-Sign_symptom
. . O

He PRP O
was VBD O
on IN O
no DT B-Medication
regular JJ I-Medication
medication NN I-Medication
, , O
but CC O
had VBD O
discontinued VBN O
Pentasa NNP B-Medication
4 CD O
months NNS O
earlier RB O
. . O

One CD O
month NN O
earlier RBR O
he PRP O
had VBD O
undergone RP O
a DT O
laparotomy NN B-Therapeutic_procedure
to TO O
excise VB O
a DT O
complex JJ B-Detailed_description
ileo NN B-Detailed_description
- : I-Detailed_description
cutaneous JJ I-Detailed_description
fistula NN B-Sign_symptom
with IN O
blind JJ B-Detailed_description
tracts NNS I-Detailed_description
, , O
and CC O
two CD O
weeks NNS O
earlier RBR O
a DT O
defunctioning VBG B-Detailed_description
ileostomy NN B-Therapeutic_procedure
had VBD O
been VBN O
created VBN O
in IN O
view NN O
of IN O
persistent JJ B-Detailed_description
abdominal JJ B-Biological_structure
pain NN B-Sign_symptom
. . O

The DT O
cutaneous JJ B-Biological_structure
fistula NN B-Sign_symptom
had VBD B-Duration
been VBN I-Duration
present JJ I-Duration
for IN I-Duration
a DT I-Duration
year NN I-Duration
, , O
but CC O
was VBD O
associated VBN O
with IN O
a DT O
terminal JJ B-Detailed_description
ileal NN B-Biological_structure
stricture NN B-Sign_symptom
and CC O
ileo JJ B-Biological_structure
- : I-Biological_structure
rectal JJ I-Biological_structure
fistula NN B-Sign_symptom
of IN B-Duration
at IN I-Duration
least JJS I-Duration
2 CD I-Duration
years NNS I-Duration
duration NN I-Duration
. . O

His PRP$ O
bowel NN O
disease NN O
had VBD O
been VBN O
resistant JJ O
to TO O
immunosuppressive VB O
drugs NNS O
including VBG O
azathioprine NN B-Medication
, , O
corticosteroiods NNS B-Medication
and CC O
three CD B-Dosage
infusions NNS I-Dosage
of IN O
Infliximab NNP B-Medication
a DT O
year NN O
earlier RBR O
. . O

There EX O
had VBD O
been VBN O
no RB B-Sign_symptom
extra JJ I-Sign_symptom
- : I-Sign_symptom
intestinal JJ I-Sign_symptom
manifestations NNS I-Sign_symptom
. . O

On IN O
admission NN O
to TO O
the DT O
hospital NN B-Nonbiological_location
, , O
he PRP O
was VBD O
thin JJ B-Sign_symptom
, , O
afebrile JJ B-Sign_symptom
with IN O
a DT O
resting VBG B-Detailed_description
tachycardia NN B-Sign_symptom
of IN O
125 CD B-Lab_value
/ JJ I-Lab_value
minute NN I-Lab_value
. . O

The DT O
rest NN O
of IN O
the DT O
cardio NN B-Diagnostic_procedure
- : I-Diagnostic_procedure
respiratory NN I-Diagnostic_procedure
examination NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
. . O

The DT O
abdomen NNS B-Biological_structure
was VBD O
minimally RB B-Severity
tender JJR B-Sign_symptom
around IN O
the DT O
ileostomy NN B-Biological_structure
without IN B-Detailed_description
guarding VBG I-Detailed_description
or CC I-Detailed_description
rebound VB I-Detailed_description
tenderness NN I-Detailed_description
. . O

Examination NN B-Diagnostic_procedure
of IN I-Diagnostic_procedure
the DT I-Diagnostic_procedure
skin NN I-Diagnostic_procedure
revealed VBD O
some DT O
pustules NNS B-Sign_symptom
and CC O
crusts NNS B-Sign_symptom
around IN O
the DT O
elbows NNS B-Biological_structure
, , O
ankles NNS B-Biological_structure
and CC O
feet NNS B-Biological_structure
( ( O
Fig NNP O
1 CD O
and CC O
2 CD O
) ) O
. . O

The DT B-Other_event
buttocks NNS I-Other_event
were VBD I-Other_event
spared VBN I-Other_event
. . I-Other_event

There EX O
were VBD O
clinical JJ O
signs NNS O
of IN O
synovitis NN B-Sign_symptom
of IN O
the DT O
wrists NNS B-Biological_structure
, , O
proximal JJ B-Biological_structure
interphalangeal NN I-Biological_structure
and CC O
metacarpophalangeal NN B-Biological_structure
joints NNS B-Biological_structure
, , O
and CC O
also RB O
both DT B-Biological_structure
ankles NNS I-Biological_structure
. . O

Results NNS O
of IN O
the DT O
laboratory NN B-Diagnostic_procedure
tests NNS I-Diagnostic_procedure
showed VBD O
a DT O
haemoglobin NN B-Diagnostic_procedure
of IN O
13 CD B-Lab_value
. . I-Lab_value
1 CD I-Lab_value
gm JJ I-Lab_value
/ NNP I-Lab_value
dl NN I-Lab_value
, , O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
count NN I-Diagnostic_procedure
15 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
× JJ I-Lab_value
109 CD I-Lab_value
/ JJ I-Lab_value
L NNP I-Lab_value
, , O
platelets VBZ B-Diagnostic_procedure
585 CD B-Lab_value
× NN I-Lab_value
109 CD I-Lab_value
/ NN I-Lab_value
L NNP I-Lab_value
, , O
C NNP B-Diagnostic_procedure
- : I-Diagnostic_procedure
reactive JJ I-Diagnostic_procedure
protein NN I-Diagnostic_procedure
37 CD B-Lab_value
. . I-Lab_value
7 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
L NNP I-Lab_value
and CC O
erythrocyte JJ B-Diagnostic_procedure
sedimentation NN I-Diagnostic_procedure
rate NN I-Diagnostic_procedure
69 CD B-Lab_value
mm NN I-Lab_value
/ NNP I-Lab_value
hr NN I-Lab_value
. . O

Urea NNP B-Diagnostic_procedure
and CC O
electrolytes NNS B-Diagnostic_procedure
, , O
complement NN B-Diagnostic_procedure
, , O
urine JJ B-Diagnostic_procedure
analysis NN I-Diagnostic_procedure
and CC O
microscopy NN B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

Rheumatoid NNP B-Diagnostic_procedure
factor NN I-Diagnostic_procedure
, , O
antinuclear JJ B-Detailed_description
and CC O
antineutrophil JJ B-Detailed_description
cytoplasmic JJ B-Diagnostic_procedure
antibodies NNS I-Diagnostic_procedure
, , O
cryoglobulins NNS B-Diagnostic_procedure
and CC O
Hepatitis NNP B-Diagnostic_procedure
B NNP I-Diagnostic_procedure
and CC I-Diagnostic_procedure
C NNP I-Diagnostic_procedure
serology NN I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

Transthoracic NNP B-Biological_structure
echocardiogram NN B-Diagnostic_procedure
showed VBD O
no DT B-Sign_symptom
signs NNS I-Sign_symptom
of IN I-Sign_symptom
endocarditis NN I-Sign_symptom
, , O
and CC O
multiple JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cultures NNS I-Diagnostic_procedure
were VBD O
sterile JJ B-Lab_value
. . O

A DT O
skin JJ B-Biological_structure
biopsy NN B-Diagnostic_procedure
from IN O
the DT O
ankle NN O
revealed VBD O
a DT O
perivascular JJ B-Biological_structure
lymphohistiocytic JJ B-Biological_structure
infiltrate NN B-Biological_structure
with IN O
prominent JJ O
neutrophils NNS B-Biological_structure
and CC O
associated VBN O
fibrinoid JJ B-Detailed_description
necrosis NN B-Sign_symptom
of IN O
vessels NNS B-Biological_structure
consistent JJ O
with IN O
` `` O
leukocytoclastic JJ B-Detailed_description
` `` O
vasculitis NN B-Disease_disorder
. . O

He PRP O
was VBD O
commenced VBN O
on IN O
60 CD B-Dosage
mg NN I-Dosage
prednisolone NN B-Medication
per IN B-Dosage
day NN I-Dosage
leading VBG O
to TO O
prompt VB B-Detailed_description
and CC O
complete JJ B-Detailed_description
resolution NN B-Sign_symptom
of IN I-Sign_symptom
all DT I-Sign_symptom
features NNS I-Sign_symptom
. . O

The DT O
dose NN O
of IN O
prednisolone NN B-Medication
was VBD O
rapidly RB O
tapered VBN O
over IN B-Duration
the DT I-Duration
course NN I-Duration
of IN I-Duration
one CD I-Duration
month NN I-Duration
by IN O
the DT O
patient NN O
, , O
faster JJR O
than IN O
advised VBN O
but CC O
without IN B-Sign_symptom
any DT I-Sign_symptom
recurrence NN I-Sign_symptom
over IN B-Duration
the DT I-Duration
following JJ I-Duration
3 CD I-Duration
years NNS I-Duration
. . O

-DOCSTART- NN -X-

A DT O
69 CD B-Age
- : I-Age
year NN I-Age
- : I-Age
old JJ I-Age
woman NN O
with IN O
a DT O
history NN O
of IN O
hypertension NN B-Disease_disorder
presented VBN O
with IN O
a DT O
generalized JJ B-Detailed_description
petechial JJ B-Detailed_description
rash NN B-Sign_symptom
and CC O
shortness NN B-Sign_symptom
of IN I-Sign_symptom
breath NN I-Sign_symptom
of IN O
3 CD B-Duration
days NNS I-Duration
duration NN I-Duration
. . O

The DT O
rash NN O
was VBD O
nonpruritic JJ B-Detailed_description
, , O
painless JJ B-Detailed_description
, , O
and CC O
started VBD O
at IN O
the DT O
thighs NNS B-Biological_structure
, , O
but CC O
rapidly RB O
disseminated VBD O
to TO O
the DT O
rest NN B-Biological_structure
of IN I-Biological_structure
the DT I-Biological_structure
body NN I-Biological_structure
. . O

She PRP O
had VBD O
progressive JJ B-Detailed_description
dyspnea NN B-Sign_symptom
on IN O
exertion NN B-Detailed_description
, , O
with IN O
a DT O
significant JJ O
decrease NN B-Lab_value
in IN O
exercise NN B-Diagnostic_procedure
tolerance NN I-Diagnostic_procedure
. . O

She PRP O
denied VBD O
fever NN B-Sign_symptom
, , O
headache NN B-Sign_symptom
, , O
dizziness NN B-Sign_symptom
, , O
hemoptysis NN B-Sign_symptom
, , O
or CC O
bleeding VBG B-Sign_symptom
from IN O
anywhere RB B-Biological_structure
. . O

There EX O
was VBD O
no DT O
history NN O
of IN O
new JJ O
drug NN O
use NN O
, , O
unusual JJ B-Activity
food NN I-Activity
intake NN I-Activity
, , O
contact NN O
with IN O
any DT O
sick JJ O
persons NNS O
, , O
or CC O
recent JJ O
travel NN B-Activity
. . O

Her PRP$ O
only JJ O
medication NN O
was VBD O
enalapril NN B-Medication
, , O
which WDT O
she PRP O
had VBD O
been VBN O
taking VBG O
for IN O
several JJ B-Duration
years NNS I-Duration
. . O

The DT O
patient NN O
denied VBD O
any DT O
use NN O
of IN O
recreational JJ B-Activity
drugs NNS I-Activity
, , O
tobacco NN B-Activity
, , O
or CC O
alcohol NN B-Activity
. . O

On IN O
admission NN O
, , O
she PRP O
was VBD O
afebrile RB B-Sign_symptom
, , O
normotensive JJ B-Sign_symptom
with IN O
mild JJ B-Severity
tachypnea NN B-Sign_symptom
( ( O
respiratory JJ B-Diagnostic_procedure
rate NN I-Diagnostic_procedure
of IN O
22 CD B-Lab_value
breaths NNS I-Lab_value
per IN I-Lab_value
minute NN I-Lab_value
) ) O
. . O

Physical JJ B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
scattered JJ O
petechial JJ B-Detailed_description
rash NN B-Sign_symptom
, , O
more RBR O
prominent JJ O
in IN O
lower JJR B-Biological_structure
extremities NNS I-Biological_structure
, , O
nonpalpable JJ B-Detailed_description
and CC O
nonblanching NN B-Detailed_description
. . O

Chest NNP B-Diagnostic_procedure
auscultation NN I-Diagnostic_procedure
revealed VBD O
coarse JJ B-Detailed_description
crackles NNS B-Sign_symptom
bilaterally RB B-Detailed_description
. . O

Cardiovascular NNP B-Biological_structure
, , O
abdominal JJ B-Biological_structure
, , O
and CC O
neurological JJ B-Detailed_description
examinations NNS B-Diagnostic_procedure
were VBD O
normal JJ B-Lab_value
. . O

There EX O
was VBD O
no DT O
palpable JJ O
lymphadenopathy NN B-Sign_symptom
or CC O
visceromegaly NN B-Sign_symptom
. . O

Laboratory NNP B-Diagnostic_procedure
examination NN I-Diagnostic_procedure
revealed VBD O
thrombocytopenia NN B-Sign_symptom
( ( O
platelets NNS B-Diagnostic_procedure
7000 CD B-Lab_value
/ NNP I-Lab_value
μL NNP I-Lab_value
) ) O
, , O
anemia NN B-Sign_symptom
( ( O
hemoglobin JJ B-Diagnostic_procedure
10 CD B-Lab_value
. . I-Lab_value
8 CD I-Lab_value
mg JJ I-Lab_value
/ NNP I-Lab_value
dL NN I-Lab_value
and CC O
hematocrit VB B-Diagnostic_procedure
34 CD B-Lab_value
% NN I-Lab_value
) ) O
, , O
and CC O
leukocytosis NN B-Sign_symptom
( ( O
white JJ B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
cells NNS I-Diagnostic_procedure
[ VBP O
WBCs NNP B-Diagnostic_procedure
] NNP O
11,600 CD B-Lab_value
/ NNP I-Lab_value
μL NNP I-Lab_value
) ) O
. . O

The DT O
coagulation NN B-Diagnostic_procedure
profile NN I-Diagnostic_procedure
was VBD O
normal JJ B-Lab_value
, , O
which WDT O
excluded VBD O
disseminated VBD B-Disease_disorder
intravascular JJ I-Disease_disorder
coagulation NN I-Disease_disorder
. . O

Arterial NNP B-Diagnostic_procedure
blood NN I-Diagnostic_procedure
gas NN I-Diagnostic_procedure
on IN O
ambient JJ B-Detailed_description
air NN I-Detailed_description
revealed VBD O
a DT O
partial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
oxygen NN I-Diagnostic_procedure
( ( O
PaO2 NNP B-Diagnostic_procedure
) ) O
of IN O
64 CD B-Lab_value
Torr NNP I-Lab_value
, , O
a DT O
partial JJ B-Diagnostic_procedure
pressure NN I-Diagnostic_procedure
of IN I-Diagnostic_procedure
carbon NN I-Diagnostic_procedure
dioxide NN I-Diagnostic_procedure
( ( O
PaCO2 NNP B-Diagnostic_procedure
) ) O
of IN O
37 CD B-Lab_value
Torr NNP I-Lab_value
( ( O
pH JJ B-Diagnostic_procedure
7 CD B-Lab_value
. . I-Lab_value
45 CD I-Lab_value
) ) O
, , O
and CC O
an DT O
increased VBN B-Lab_value
alveolar JJ B-Diagnostic_procedure
- : I-Diagnostic_procedure
arterial JJ I-Diagnostic_procedure
gradient NN I-Diagnostic_procedure
( ( O
44 CD B-Lab_value
Torr NNP I-Lab_value
) ) O
. . O

Diffuse NNP B-Detailed_description
airspace NN B-Sign_symptom
consolidation NN I-Sign_symptom
was VBD O
found VBN O
on IN O
chest NN B-Biological_structure
roentgenogram NN B-Diagnostic_procedure
( ( O
Fig NNP O
. . O
1A CD O
) ) O
. . O

Computed VBN B-Diagnostic_procedure
tomography NN I-Diagnostic_procedure
( ( O
CT NNP B-Diagnostic_procedure
) ) O
of IN O
the DT O
chest NN B-Biological_structure
showed VBD O
diffuse IN B-Detailed_description
ground NN B-Texture
glass NN I-Texture
alveolar JJ B-Biological_structure
opacities NNS B-Sign_symptom
and CC O
patchy NN B-Detailed_description
infiltrates NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
1B CD O
, , O
C NNP O
) ) O
. . O

She PRP O
was VBD O
started VBN O
on IN O
broad JJ B-Detailed_description
- : I-Detailed_description
spectrum NN I-Detailed_description
antibiotics NNS B-Medication
and CC O
received VBD O
intravenous JJ O
steroids NNS B-Medication
. . O

Peripheral JJ B-Diagnostic_procedure
smear NN I-Diagnostic_procedure
showed VBD O
giant JJ B-Sign_symptom
platelets NNS I-Sign_symptom
and CC O
occasional JJ B-Detailed_description
small JJ B-Detailed_description
platelet NN B-Sign_symptom
clumps NNS I-Sign_symptom
, , O
with IN O
no DT O
schistocytes NNS B-Sign_symptom
. . O

A DT O
flexible JJ B-Diagnostic_procedure
fiber NN I-Diagnostic_procedure
- : I-Diagnostic_procedure
optic JJ I-Diagnostic_procedure
bronchoscopy NN I-Diagnostic_procedure
( ( O
FFB NNP B-Diagnostic_procedure
) ) O
showed VBD O
normal JJ B-Lab_value
mucosa NN B-Diagnostic_procedure
with IN O
no DT O
endobronchial JJ B-Biological_structure
lesions NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
2A CD O
) ) O
. . O

Serial JJ O
aliquots NNS O
of IN O
BAL NNP B-Diagnostic_procedure
fluid NN I-Diagnostic_procedure
( ( O
BALF NNP B-Diagnostic_procedure
) ) O
turned VBD O
more RBR O
hemorrhagic JJ B-Sign_symptom
, , O
confirming VBG O
the DT O
bronchoscopic NN O
diagnosis NN O
of IN O
DAH NNP B-Disease_disorder
( ( O
Fig NNP O
. . O
2B CD O
) ) O
. . O

Cytology NN B-Diagnostic_procedure
of IN O
BALF NNP O
showed VBD O
a DT O
substantial JJ O
amount NN O
of IN O
hemosiderin JJ B-Detailed_description
- : I-Detailed_description
laden JJ I-Detailed_description
macrophages NNS B-Sign_symptom
, , O
further RB O
supporting VBG O
the DT O
diagnosis NN O
. . O

All DT O
BALF NNP O
cultures NNS B-Diagnostic_procedure
and CC O
gram NN B-Diagnostic_procedure
stains NNS I-Diagnostic_procedure
were VBD O
negative JJ B-Lab_value
. . O

The DT O
patient NN O
remained VBD O
with IN O
severe JJ B-Severity
thrombocytopenia NN B-Sign_symptom
and CC O
hypoxia NN B-Sign_symptom
despite IN O
steroids NNS B-Medication
and CC O
platelets NNS B-Medication
transfusion NN I-Medication
. . O

High JJ B-Dosage
doses NNS I-Dosage
of IN O
pulse JJ O
steroids NNS B-Medication
and CC O
intravenous JJ O
immunoglobulins NNS B-Medication
( ( O
IVIGs NNP O
) ) O
were VBD O
added VBN O
with IN O
clinico JJ B-Detailed_description
- : I-Detailed_description
radiological JJ I-Detailed_description
improvement NN B-Sign_symptom
. . O

A DT O
bone NN B-Diagnostic_procedure
marrow NN I-Diagnostic_procedure
aspirate NN I-Diagnostic_procedure
was VBD O
morphologically RB B-Lab_value
normal JJ I-Lab_value
. . O

Additional NNP O
laboratory NN B-Diagnostic_procedure
studies NNS I-Diagnostic_procedure
failed VBD B-Lab_value
to TO I-Lab_value
reveal VB I-Lab_value
an DT I-Lab_value
etiology NN I-Lab_value
for IN O
secondary JJ O
thrombocytopenia NN B-Sign_symptom
( ( O
Table JJ O
1 CD O
) ) O
, , O
supporting VBG O
the DT O
diagnosis NN O
of IN O
ITP NNP B-Disease_disorder
. . O

Steroids NNS B-Medication
were VBD O
gradually RB O
tapered VBN O
. . O

Repeat NN O
chest JJS B-Biological_structure
radiograph NN B-Diagnostic_procedure
showed VBD O
almost RB O
complete JJ O
resolution NN O
of IN O
bilateral JJ B-Detailed_description
infiltrates NNS B-Sign_symptom
( ( O
Fig NNP O
. . O
3 CD O
) ) O
. . O

Platelet NNP B-Diagnostic_procedure
count NN I-Diagnostic_procedure
returned VBD O
to TO O
normal JJ B-Lab_value
by IN O
week NN O
10 CD O
after IN O
admission NN O
without IN O
any DT O
additional JJ B-Therapeutic_procedure
therapies NNS I-Therapeutic_procedure
( ( O
Fig NNP O
. . O
4 CD O
) ) O
. . O

